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Protein Trafficking of BK Channel β1 Subunits in Cerebral Artery Myocytes 
Abstract 
Rationale: Large-conductance calcium (Ca2+)-activated potassium channels (BK) are expressed in arterial 
myocytes to control arterial contractility. It is composed of pore- forming BKα and auxiliary β1 subunits. 
Auxiliary β1 subunits associate with BKα which modulate Ca2+ sensitivity of BK channel. Previous data 
showed that BKα locates at cell membrane, whereas β1 subunits are primarily intracellular which 
regulated by Rab11A- positive recycling endosomes. Endothelin-1 (ET-1), a vasoconstrictor, induces 
contraction of myocytes. ET-1 inhibits BK channel but mechanisms are not fully understood. It is unclear 
that vasoconstrictors regulate the cellular distribution of BK channels. Furthermore, BK channels are 
involved in hypertension. Hypertension increases risk of major cardiovascular and cerebrovascular 
events, such as stroke and mental dysfunction. During hypertension, cerebral arteries have high myogenic 
tone and are less responsive to vasodilators, including nitric oxide (NO). The regulation of arterial 
contractility by BK channels is altered during hypertension, although mechanisms involved are also 
unclear. 
Objective: Test the hypothesis that ET-1 inhibits β1 surface trafficking in myocytes via activation of PKC. 
Test the hypothesis that activation of PKC directly modulates Rab11A through phosphorylation. 
Furthermore, test the hypothesis that trafficking of pore- forming BK channel (BKα) and auxiliary β1 
subunits contributes to pathological changes in contractility in cerebral arteries of stroke-prone 
spontaneously hypertensive rats (SP- SHRs). 
Methods and Results: ET-1 decreased NO-induced or depolarization-induced surface β1 expression and 
association with BKα in myocytes through activation of protein kinase C (PKC). Total β1, total BKα 
proteins or surface BKα was not altered by ET-1. Rab11A regulates β1 protein trafficking in Rab11A-
positive recycling endosome. ET-1 reduced Rab11 activity via phosphorylation. Five probable 
phosphorylated sites on Rab11A were identified, among which Ser177 has highest probability. A 
phosphorylation-mute Rab11A construct (Rab11A S177A) or wild-type Rab11A construct similarly 
increased total Rab11A protein in transfected myocytes. Rab11A S177A inhibited ET-1-reduced Rab11A 
activity and decreased β1 protein trafficking. Rab11A S177A reversed PKC- dependent block of single BK 
channels and transient BK currents in myocytes. Rab11A S177A partially blocked ET-1-induced 
vasoconstriction. In contrast, NO-induced surface-trafficking of β1 subunits, BK current activity and 
vasodilation did not involve Rab11A S177. Our data also indicate that the amounts of total and surface 
BKα and β1 subunits were similar in unstimulated arteries of SP-SHRs and age-matched, normotensive 
Wistar-Kyoto rat controls. In contrast, the stimulated surface-trafficking of β1 subunits by either NO 
(sodium nitroprusside, SNP) or membrane depolarization was inhibited in SP-SHR arteries. BIM, a PKC 
inhibitor, and overexpression of a mutant Rab11A construct that cannot be phosphorylated by PKC at 
serine 177 (Rab11A S177A) restored the stimulated surface-trafficking of β1 subunits. PKC-mediated 
inhibition of β1 trafficking prevented BK channel activation by NO in arterial myocytes of SP-SHRs and 
this was restored by the expression of Rab11A S177A, but not by Rab11A. Vasodilation to NO and 
lithocholate, an activator of β1 subunit-containing BK channels, was inhibited in pressurized arteries of 
SP-SHRs. Vasodilation to these agents was reestablished by BIM in SP-SHR arteries. 
Conclusions: In smooth muscle cell, ET-1 activates protein kinase C which phosphorylates Rab11A at 
Ser177 to reduce Rab11A activity. Inhibition of Rab11A blocks anterograde trafficking of β1 subunits to 
associate with BKα on cell surface. Less β1 subunits reduces Ca2+ sensitivity of BK channel and 
transient BK channel currents which leads to vasoconstriction. Spontaneously active PKC inhibits β1 
subunit trafficking in arterial myocytes and is responsible for dysfunctional NO-induced BK channel 








Jonathan H. Jaggar, Ph.D. 
Keywords 
Cell Signaling, Ion Channels, Membrane Transport, Signal Transduction, Vascular Biology 
Subject Categories 
Biological Phenomena, Cell Phenomena, and Immunity | Medical Cell Biology | Medical Physiology | 
Medical Sciences | Medicine and Health Sciences 
















The Graduate Studies Council 
The University of Tennessee 







In Partial Fulfillment 
Of the Requirements for the Degree 
Doctor of Philosophy 












































Portions of Chapters 4 and 5 © 2017 by American Heart Association, Inc. 
All other material © 2018 by Xue Zhai. 










I dedicate this dissertation 
 to my parents, Yuejin Zhai and Jin Zhang, 
to my fiancée Yichen Sun, 
to all my extended family, 









 First, I would like to thank my mentor, Dr. Jonathan H. Jaggar, for his great and 
kindly supervision and tremendous support of my studies. Without his mentorship and 
encouragement, I won’t be able to fulfill my dream. He has guided me how to design the 
research, do experiments, make presentations, and write papers. I am very appreciate his 
mentorship for the graduate education to lead my future career.  
 
 I give my sincere gratitude to my dissertation committee members Drs. 
Adebowale Adebiyi, William Earl Armstrong, Julio Cordero-Morales and Elena 
Parfenova for their valuable suggestions and insightful comments during my journey to 
phD.   
 
I am grateful for the lab instructor, Dr. Marie Dennis M. Leo who helped me 
design the project and taught me the relevant techniques. I really appreciate Dr. Qian 
Wang for teaching me the patch clamp technique. It was very precious time companioned 
by her during that difficult time. I also thank lab former and current colleagues Dr. John 
P. Bannister, Kirk W. Evanson, Raquib Hasan, Priya Muralidharan and Michael W. Kidd 
for their kind assistance for my research studies. 
 
I would like to thank the University of Tennessee Health Science Center for give 
me the awesome opportunity to purse doctorate degree. My appreciation also gives the 
Department of Physiology for the facilities, seminars and all kinds of assistantship. I also 
sincerely thank Mr. and Mrs. Gerwin for awarding me the Gerwin Graduate Scholarship 
to support my research.  
 
I am forever indebted to my patients and my extended family for their 
unconditional love, care and support. Finally, praise the Lord and give glory to God for 









Rationale: Large-conductance calcium (Ca2+)-activated potassium channels (BK) are 
expressed in arterial myocytes to control arterial contractility. It is composed of pore-
forming BKα and auxiliary β1 subunits. Auxiliary β1 subunits associate with BKα which 
modulate Ca2+ sensitivity of BK channel. Previous data showed that BKα locates at cell 
membrane, whereas β1 subunits are primarily intracellular which regulated by Rab11A-
positive recycling endosomes. Endothelin-1 (ET-1), a vasoconstrictor, induces 
contraction of myocytes. ET-1 inhibits BK channel but mechanisms are not fully 
understood. It is unclear that vasoconstrictors regulate the cellular distribution of BK 
channels. Furthermore, BK channels are involved in hypertension. Hypertension 
increases risk of major cardiovascular and cerebrovascular events, such as stroke and 
mental dysfunction. During hypertension, cerebral arteries have high myogenic tone and 
are less responsive to vasodilators, including nitric oxide (NO). The regulation of arterial 
contractility by BK channels is altered during hypertension, although mechanisms 
involved are also unclear.   
 
Objective: Test the hypothesis that ET-1 inhibits β1 surface trafficking in myocytes via 
activation of PKC. Test the hypothesis that activation of PKC directly modulates Rab11A 
through phosphorylation. Furthermore, test the hypothesis that trafficking of pore-
forming BK channel (BKα) and auxiliary β1 subunits contributes to pathological changes 
in contractility in cerebral arteries of stroke-prone spontaneously hypertensive rats (SP-
SHRs). 
 
Methods and Results: ET-1 decreased NO-induced or depolarization-induced surface β1 
expression and association with BKα in myocytes through activation of protein kinase C 
(PKC). Total β1, total BKα proteins or surface BKα was not altered by ET-1. Rab11A 
regulates β1 protein trafficking in Rab11A-positive recycling endosome. ET-1 reduced 
Rab11 activity via phosphorylation. Five probable phosphorylated sites on Rab11A were 
identified, among which Ser177 has highest probability. A phosphorylation-mute 
Rab11A construct (Rab11A S177A) or wild-type Rab11A construct similarly increased 
total Rab11A protein in transfected myocytes. Rab11A S177A inhibited ET-1-reduced 
Rab11A activity and decreased β1 protein trafficking. Rab11A S177A reversed PKC-
dependent block of single BK channels and transient BK currents in myocytes. Rab11A 
S177A partially blocked ET-1-induced vasoconstriction. In contrast, NO-induced 
surface-trafficking of β1 subunits, BK current activity and vasodilation did not involve 
Rab11A S177. Our data also indicate that the amounts of total and surface BKα and β1 
subunits were similar in unstimulated arteries of SP-SHRs and age-matched, 
normotensive Wistar-Kyoto rat controls. In contrast, the stimulated surface-trafficking of 
β1 subunits by either NO (sodium nitroprusside, SNP) or membrane depolarization was 
inhibited in SP-SHR arteries. BIM, a PKC inhibitor, and overexpression of a mutant 
Rab11A construct that cannot be phosphorylated by PKC at serine 177 (Rab11A S177A) 
restored the stimulated surface-trafficking of β1 subunits. PKC-mediated inhibition of β1 
trafficking prevented BK channel activation by NO in arterial myocytes of SP-SHRs and 
this was restored by the expression of Rab11A S177A, but not by Rab11A. Vasodilation 
 
vi 
to NO and lithocholate, an activator of β1 subunit-containing BK channels, was inhibited 
in pressurized arteries of SP-SHRs. Vasodilation to these agents was reestablished by 
BIM in SP-SHR arteries. 
 
Conclusions: In smooth muscle cell, ET-1 activates protein kinase C which 
phosphorylates Rab11A at Ser177 to reduce Rab11A activity. Inhibition of Rab11A 
blocks anterograde trafficking of β1 subunits to associate with BKα on cell surface. Less 
β1 subunits reduces Ca2+ sensitivity of BK channel and transient BK channel currents 
which leads to vasoconstriction. Spontaneously active PKC inhibits β1 subunit trafficking 
in arterial myocytes and is responsible for dysfunctional NO-induced BK channel 
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Cardiovascular system consists of vascular tubes that transports blood from heart 
to peripheral tissues and then returns blood back to heart. Vascular system contains 
various types of blood vessels in human body, i.e., arteries, arterioles, capillaries, venues 
and veins. (Eric Widmaier 2002) Three layers have been identified within blood vessels, 
that is, tunica intima, tunica media and tunica adventitia. (Eric Widmaier 2002) Tunica 
intima is a simple squamous epithelium which is called endothelium. (Eric Widmaier 
2002) The inner part of entire cardiovascular system is covered by the continuous layer of 
endothelium. (Eric Widmaier 2002) Tunica media locates in the middle of vascular wall 
which contains smooth muscle cells. (Eric Widmaier 2002) Tunica adventitia is made of 
connective tissue as well as nerves that go with it. (Eric Widmaier 2002) Arterial vessels 
transport oxygenized blood to tissues to provide oxygen and nutrition. (Eric Widmaier 
2002) Venous vessels drain the deoxygenized blood back to heart. (Eric Widmaier 2002) 
Deoxygenized blood goes through right atrial to right ventricle where it is pumped into 
pulmonary arteries. (Eric Widmaier 2002) In the lung, deoxygenized blood exchanges its 
carbon dioxide with oxygen and turns into oxygenized blood. (Eric Widmaier 2002) 
 
Blood vessel size is regulated by changing its diameter of lumen. Constriction or 
dilation of arteries is controlled by contraction or relaxation of vascular smooth muscle 
cells, respectively. Sympathetic fibers of autonomic nervous system innervate vascular 
smooth muscle. (Eric Widmaier 2002) An increase in sympathetic output stimulates 
myocytes to contract, resulting in narrowing the lumen. A decrease in the diameter of the 
lumen of a blood vessel is called vasoconstriction. In contrast, vasodilation is the process 
of blood vessel dilation leading to an increase in lumen diameter. (Eric Widmaier 2002) 
 
Vascular resistance is the product of vessel length and blood viscosity, reversed 
by radius. (Eric Widmaier 2002) The blood pressure is the product of cardiac output (CO) 
and systemic vascular resistance (SVR). (Eric Widmaier 2002) The equation is BP = CO 
× SVR. So increased intravascular volume or increased systemic vascular resistance 
results in elevated blood pressure.  
 
 
Vascular Smooth Muscle Cells 
 
Smooth muscle cells, or myocytes are located in tunica media of blood vessels. 
(Eric Widmaier 2002) Myocytes are innervated by sympathetic nerves through 
adrenoceptors such as α1, α2, β2 receptor. (Eric Widmaier 2002) Like skeletal muscle, 
myocytes contain thick myosin filaments and thin actin filaments. (Eric Widmaier 2002) 
Moreover, intermediate filaments attach to the structures called dense bodies in smooth 






Ca2+ dependent smooth muscle contraction 
 
Intracellular Ca2+ concentration controls the contractile activity in myocytes. 
(Brozovich, Nicholson et al. 2016) Ca2+ stimulates cross-bridge cycle between myosin 
and actin which is controlled by Ca2+ regulated enzyme. (Figure 1-1) Intracellular Ca2+ 
concentration maintains a basal level of cross-bridge activity which is known as smooth 
muscle tone. (Brozovich, Nicholson et al. 2016) Intracellular Ca2+ binds to calmodulin. 
Ca2+ calmodulin complex binds to a 20 kDa regulatory Ser/Thr kinase called myosin light 
chain kinase (MLCK) therefore Ca2+ calmodulin complex activates MLCK. MLCK is a 
Ca2+/ Calmodulin dependent kinase which is stimulated by intracellular Ca2+ rise. Active 
MLCK uses ATP to phosphorylate myosin light chains. (Figure 1-1) Smooth muscle 
myosin is phosphorylated at Ser 19 of myosin light chain kinase (MLCK). (Ito and 
Hartshorne 1990) Then phosphorylated myosin moves the cross-bridge to bind to actin 
which results in contraction of smooth muscle cell. (Ito and Hartshorne 1990) 
Dephosphorylation occurs during relaxation of myocytes because dephosphorylated 
myosin did not bind to actin. Myosin phosphatase decreases myosin activity by 
dephosphorylation of myosin. (Archer, Huang et al.) 
 
 
Ca2+ independent smooth muscle contraction 
 
The process of Ca2+ independent contraction mechanism is dependent on MLCK 
activation with subsequent actin-myosin cross-bridging. (Brozovich, Nicholson et al. 
2016) Myosin light chain phosphatase (MLCP) removes the high-energy phosphate group 
from myosin thereby causing relaxation. (Brozovich, Nicholson et al. 2016) RhoA/Rho 
kinase pathway inhibits dephosphorylation of myosin light chain by myosin light chain 
phosphatase. (Schmidt and Hall 2002) RhoA is activated by exchanging of GDP for GTP. 
Active RhoA stimulates Rho kinase, a serine/threonine kinase. Rho kinase inhibits MLCP 
by phosphorylation, thus prevents myosin light chain dephosphorylation in order to 
maintain contraction. (Brozovich, Nicholson et al. 2016) Furthermore, actin binding 
protein caldesmon is phosphorylated by ERK. (Bryan 1990, Wang, Wang et al. 1991) 
Caldesmon in myocytes functions as troponin complex in striated muscle which it 
inhibits the ATPase activity of myosin and blocks the cross-bridge of myosin and action. 
(Bryan 1990, Wang, Wang et al. 1991) Myosin ATPase activity is inhibited by C 





Large-conductance Ca2+-activated potassium (BK) channel, also known as 
Slo1/MaxiK/KCa1.1 channel, expresses in a various types of tissues. (Jaggar, Porter et al. 
2000) BK channel most commonly expresses in neuron as well as smooth muscle cells. It 
is also detected in liver, spleen, pancreas, adrenal glands, ovary and testes. As its term 
indicates, BK channel exhibits a large conductance (~ 250-300 pS) in symmetrical 150 
mM K+. (Jaggar, Porter et al. 2000) BK channel functions in maintaining the dynamic 





Figure 1-1. Schematic diagram of smooth muscle contraction.  
 
Notes: Membrane depolarization activates voltage dependent Ca2+ channels. Voltage 
dependent Ca2+ channels (VDCC) induce Ca2+ entry and increase global Ca2+. Ca2+ binds 
to calmodulin which forms Ca2+-calmodulin complex. Ca2+-calmodulin complex further 
stimulates myosin light chain kinase (MLCK). MLCK phosphorylates light chains in 







in outward efflux of potassium which shifts the membrane potentials more negatively. So 
BK channel regulates myocyte membrane potential thereby arterial contractility. 
 
 
BK channel function 
 
Membrane depolarization elevates intracellular Ca2+ which activates BK 
channels. Membrane depolarization opens voltage dependent Ca2+ channel which results 
in Ca2+ influx into the cell. (Jaggar, Porter et al. 2000) The intracellular Ca2+ rise is 
pumped into sarcoplasmic reticulum by sarcoplasmic reticulum Ca2+ ATPase. (Jaggar, 
Porter et al. 2000) Sarcoplasmic reticulum Ca2+ load activates the ryanodine receptors, 
which generate localized Ca2+ sparks that activate BK channel. (Jaggar, Porter et al. 
2000) Activated BK channels would induce hyperpolarization which inhibits voltage 
dependent Ca2+ channel and reduces Ca2+ entry. (Jaggar, Porter et al. 2000) So BK 





BK channel is comprised of four pore-forming α subunits. (Hu and Zhang 2012, 
Yang, Zhang et al. 2015) It was first found in the Drosophila slowpoke mutant in 1980s. 
(Elkins, Ganetzky et al. 1986) The BKα subunits are encoded by KCNMA1 gene (a.k.a 
SLO). (Hu and Zhang 2012, Yang, Zhang et al. 2015) The BKα subunit contains seven 
transmembrane helices (S0-S7) which form a voltage sensor domain and a pore gate 
domain as well as a large COOH terminal region. (Yang, Zhang et al. 2015) 
Transmembrane segment S0 forms an extracellular N terminus. (Yang, Zhang et al. 2015)  
S1-S4 helices form the primary voltage sensor domain (VSD). (Yang, Zhang et al. 2015)  
Membrane depolarization induces conformational change in the voltage sensor domain 
by twisting of S4 segment upwardly. (Yang, Zhang et al. 2015) Charged arginine in S4 
domain contributes to the gating charge, specifically Arg213, Asp153, Arg167 and 
Asp186, which are voltage sensing. (Stefani, Ottolia et al. 1997, Ma, Lou et al. 2006) S5-
S6 helices form the pore gate domain. (Jiang, Pico et al. 2001) The cytosolic tail domain 
includes two regulators of conductance for K+ (RCK domain). (Jiang, Pico et al. 2001) 
The second RCK domain contains Ca2+ bowl which is a high affinity binding site for 
Ca2+. (Jiang, Lee et al. 2002) Four RCK domains are assembled to form a gating ring 
which can change its conformation upon Ca2+ binding. (Hu and Zhang 2012) A heme 
binding site locates at a region between two RCK domains (Hou, Heinemann et al. 2009), 
which inhibits channel activity in the presence of heme. (Tang, Santarelli et al. 2004) The 
voltage sensor domains transduce membrane potential changes which are coupled to the 
gate domain. (Hu and Zhang 2012) The BK channel activity is subject to regulation by a 
great variety of biological factors such as nitric oxide (NO), carbon monoxide (CO), 
steroid hormones, reactive oxygen species (Amberg, Bonev et al.), protons (H+), heme, 








BK channels auxiliary β subunits consist of two transmembrane domains 
connected by a long extracellular loop, which can co-assemble with α subunits. (Hu and 
Zhang 2012)  Four types of β subunits (β1-β4) of BK channel have been identified and β1 
subunit is mainly expressed in the smooth muscle cells, β4 is expressed in neural tissue. 
(Kyle and Braun 2014) Voltage sensor domain is stabilized in its active form by β1, β2 
and β4 subunits (Contreras, Neely et al. 2012). The β2 and some variants of β3 subunits 
induce inactivation of BK channel through N-termini. (Wallner, Meera et al. 1999) 
(Uebele, Lagrutta et al. 2000) Up to four auxiliary β1 subunits can co-assemble with the 
tetrameric BKα subunits, particularly interact with N-terminal S0-S2 segment which 
regulate the gating property of BK channels. (Hu and Zhang 2012) The β1 subunits have 
been shown to elevate Ca2+ sensitivity and modulate gating properties. (Wu and Marx 
2010) The β subunits also enhance the coupling of ryanodine receptor mediated Ca2+ 
sparks to spontaneous transient outward currents (STOCs) which subsequently reduce 
Ca2+ influx and result in relaxation. (Jaggar, Porter et al. 2000) The studies of knock-out 
β1 subunits mice show that a decrease in the calcium sensitivity of BK channels and a 
reduction in calcium sparks so that the vascular relaxation mechanism is significantly 
impaired and mean arterial blood pressure is significantly elevated. (Brenner, Perez et al. 
2000) Mutation of G352A in β1 gene of BK channels has been shown to associate with 
low prevalence of diastolic hypertension in an epidemiological study. (Fernandez-
Fernandez, Tomas et al. 2004) Expressing a mutant form, β1 E65K, together with wild 
type β1 subunits in HEK 293 cells, enhanced Ca2+ sensitivity of BK channels. 
(Fernandez-Fernandez, Tomas et al. 2004) So β1 subunits are essential for regulation of 





Ca2+ sparks represent rapid spatially localized Ca2+ rise released from Ryanodine-
sensitive Ca2+ channels (RyR) of sarcoplasmic reticulum (Kilts, Gerhardt et al.) (Kilts, 
Gerhardt et al.). Smooth muscle SRs are within 20 nm to cell membrane, indicating a 
direct communication between SR and cell membrane BK channels. (Devine, Somlyo et 
al. 1972) RyR channels are first found by activation of a plant alkaloid ryanodine in 
striated muscle of insect. (Sutko and Airey 1996) Three RyR channels have been 
identified as RyR1, RyR2 and RyR3 which express in skeletal muscle, cardiac muscle 
and brain respectively. (Jaggar, Porter et al. 2000) RyR receptors generate micromolar 
elevation of Ca2+ with a rise time of ~20 ms which activates nearby BK channels. (Bonev 
and Nelson 1993) The frequency of Ca2+ sparks is about 1 Hz in resting potential of rat 
cerebral artery myocytes. (Jaggar, Porter et al. 2000) Fill width at half maximal amplitude 
of Ca2+ sparks is around 2~3 um. (Jaggar, Stevenson et al. 1998) Ca2+ sparks have no 
effect on contractility directly due to their limited spatial reach and no alteration of global 
Ca2+ concentration. (Jaggar, Porter et al. 2000) BK channel has a low Ca2+ affinity which 
could not be stimulated by global Ca2+. The decay of Ca2+ sparks is caused by diffusion, 
uptake Ca2+ into SR and extrusion. (Santana, Kranias et al. 1997) Elevation of cGMP or 
cAMP increased Ca2+ sparks frequency and subsequently activates BK channel activity. 
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(Jaggar, Wellman et al. 1998, Porter, Bonev et al. 1998) Phospholamban dissociated from 
SR Ca2+ -ATPase after phosphorylation by PKG or PKA, resulting in an increase in SR 
Ca2+ load. (Santana, Kranias et al. 1997) (ZhuGe, Tuft et al. 1999) Activation of PKC 
reduced Ca2+ sparks and subsequently STOC frequency and amplitude in myocytes from 





A leucine-rich repeat containing subunits (LRRCs), referred to as γ subunits have 
been identified in the BKα pull-down components which can regulate BK channel 
activity. (Evanson, Bannister et al. 2014) The ~35kDa LRRC protein is classified as 
another type of BK channel auxiliary subunit due to its functionally and structurally 
distinction. (Evanson, Bannister et al. 2014) The LRR domain contains repeating 20-29 
residue leucine rich sequence. (Evanson, Bannister et al. 2014) LRRC proteins are 
characterized by the consensus sequence: LXXLXLXX N/C XL, where L is leucine, 
isoleucine or phenylalanine and X is any amino acid. (Yan and Aldrich 2012) LRRC 26, 
38, 52 and 55 have been found to increase voltage sensitivity of BK channels and shift to 
hyperpolarization direction. (Yan and Aldrich 2012) LRCC26 subunits induce a large 
negative voltage shift (~ -140mV) in BK channel activation. (Yan and Aldrich 2012) 
LRCC26 has been found to be expressed and associated with BKα channels in cerebral 
arteries. (Evanson, Bannister et al. 2014) LRCC26 increases voltage- and Ca2+ sensitivity 
of BK channel. (Evanson, Bannister et al. 2014) 
 
 
Post translational modification 
 
 BK channels are subjective to extensive post-translational modifications which 
significantly change the property of channel function. (Kyle and Braun 2014) Ser/Thr/Tyr 
residues in pore-forming α subunit are modified by protein kinases or protein 
phosphatases. (Kyle and Braun 2014) Adenylyl cyclase catalyzes ATP into cyclic AMP. 
Protein kinase A (PKA) contains two catalytic domains which associate with two 
regulatory domains. cAMP binds to regulatory subunits of PKA which in turn releases 
catalytic domain from PKA. PKA-mediated phosphorylation of BK channel enhances BK 
channel activity. Ser873 in BK is essential for an increase in PKA-mediated BK channel 
activity. (Nara, Dhulipala et al. 1998) 
 
Many studies showed that BK channels are extensively regulated by various 
protein kinase phosphorylation. Regarding of protein kinase G (PKG) pathway, nitric 
oxide (NO) stimulates guanylyl cyclase, which results in synthesis of cGMP from GTP. 
Sodium nitroprusside releases nitric oxide. PKG-mediated mediated phosphorylation of 
BK channel also increases BK channel activity. (Robertson, Schubert et al. 1993) It has 
been reported that Ser691, 873 and 1111-1112 in the BK C-terminus are modified by 
NO/cGMP/PKG signaling pathway to enhance channel activity (Kyle, Hurst et al. 2013). 
Furthermore, the cAMP-dependent protein kinase (PKA) activates the BK channel by 
increasing Ca2+ sensitivity of the channel (White, Kryman et al. 2000). On the contrary, 
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protein kinase C inhibits BK channels in smooth muscle (Zhou, Wulfsen et al. 2010). 20-
hydroxyeicosatetraenoic acid, a protein kinase C activator, has been shown to inhibit the 
whole cell potassium current in the cerebral vascular smooth muscle (Lange, 
Gebremedhin et al. 1997). The active diacylglycerol analog has also been shown to 
reduce the potassium current by 70% in rat tail artery smooth muscle cells (Schubert, 
Noack et al. 1999). Phosphorylation of Ser695 and Ser1151 by PKC activation has been 
shown to decrease BK channel activity in myocytes. (Zhou, Wulfsen et al. 2010). Besides 
of Ser/Thr phosphorylation, BK channels are also enhanced by Src kinases and Pyk-2 
which phosphorylate Tyr in BKα subunit. (Ling 2000, Yang et al 2012) Tyr766Phe in the 






Arterial contractility is modulated by both vasoconstrictor and vasodilator stimuli, 
leading to change in regional organ blood flow and systemic blood pressure. 
Vasoconstrictors, including endothelin-1 (ET-1), decrease arterial diameter, which reduce 
organ blood flow and elevate blood pressure. (Yanagisawa, Kurihara et al. 1988) In 
contrast, vasodilators, including nitric oxide (NO), increase arterial diameter to enhance 
organ blood flow as well as reduce blood pressure. (Archer, Huang et al. 1994) 
Vasoregulatory stimuli modulate the activity of ion channels expressed in cells of the 
vascular wall, resulting in a change in membrane potential, a key determinant of 
contractility. (Nelson, Patlak et al. 1990) Many different ion channels expressed in 
arterial smooth muscle cells (myocytes) regulate membrane potential, which modulate 
Ca2+ influx through voltage-dependent Ca2+ channels thereby change intracellular Ca2+ 
concentration. (Jaggar, Porter et al. 2000) 
 
Endothelin is a twenty-one amino acid peptide discovered by Yanagisawa in 1988 
(Yanagisawa, Kurihara et al. 1988). It is a potent vasoconstrictor that has three isoforms, 
ET-1 ET-2, ET-3 (Inoue, Yanagisawa et al. 1989). Endothelin-1 is mainly generated by 
the endothelium. ET-1 acts on its receptors of smooth muscle cells via autocrine or 
paracrine pathway. (Ivey, Osman et al. 2008, Horinouchi, Terada et al. 2013) Endothelin 
receptors consist of two subtypes: ETAR and ETBR, both belong to GPCR superfamily, 
which. (Ivey, Osman et al. 2008) ETAR is highly expressed in the vascular smooth 
muscle cell that contributes to ET-1 induced contraction and proliferation. (Ivey, Osman 
et al. 2008) ETB receptors have many functions, such as clearance of ET-1, release of NO 
and prostaglandin, inhibition of endothelial cell apoptosis. (Ivey, Osman et al. 2008) 
Endothelin receptors mediate vascular contractility, cell proliferation and differentiation. 
(Ivey, Osman et al. 2008) 
 
ET-1 activates at least three signaling pathways in vascular smooth muscle cell, 
including PKC, MAPK and PI3K/PKB pathways. (Hilgers and Webb 2005) The binding 
of ET-1 to the ETA receptor activates Gq protein. (Woodsome, Polzin et al. 2006) Gq 
protein leads to activation of membrane bound enzyme phosphoinositide specific 
phospholipase C (PLC), which then hydrolyzes the membrane phospholipid 
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phosphatidylinositol-4,5-bisphosphate (PIP2) to two second messengers hydrophobic 
diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (IP3) (Hilgers and Webb 2005, 
Woodsome, Polzin et al. 2006). Binding of IP3 to the IP3 receptor triggers release of Ca
2+ 
from sarcoplasmic reticulum. (Lesh, Nixon et al. 1998) The RyR, localized on the 
sarcoplasmic reticulum, facilitates IP3 to bind IP3 receptor. (Lesh, Nixon et al. 1998) 
RyR-mediated Ca2+ channels lead to a rapid increase in Ca2+ concentration. (Lesh, Nixon 
et al. 1998) Ca2+ binds calmodulin to form a Ca2+ -calmodulin complex, which activates 
myosin light chain kinase (MLCK) to phosphorylate light chain of myosin. It enables 
interaction of myosin with actin to generate contraction. DAG, together with Ca2+, 
activates the protein kinase C. (Hilgers and Webb 2005) DAG medicates vasocontricton 
via activation of PKC. PKCα and PCKβ are dependent upon intracellular Ca2+ and 
activation of DAG. (Hilgers and Webb 2005) PKCε is dependent only on DAG. PKC 
directly phosphorylates MLCK which in turn phosphorylates MLC. (Hilgers and Webb 
2005) The phosphorylated MLC facilitates the interaction between myosin and actin 
filaments. Myosin cross bridges with actin resulting in contraction. (Hilgers and Webb 
2005) 
 
ET-1 receptor also activates Raf and mitogen-activated protein kinases (MAPK) 
cascade through phosphorylation of PKC (Moodie, Willumsen et al. 1993). PKC and 
calmodulin stimulate Ras which recruits Raf. (Moodie, Willumsen et al. 1993) Raf 
phosphorylates MAPK/ERK kinase which in turn phosphorylates extracellular signal-
regulated kinases (ERK) that controls vascular smooth muscle cell survival, 
differentiation and inflammation. (Moodie, Willumsen et al. 1993) Phosphatidylinositol-3 
(PIP3) kinase is also an effector of ET-1 action (Shi-Wen, Chen et al. 2004), which 
converts phosphatidylinositol 4,5- bisphosphate to PIP3 through phosphatidylinositol 3-
kinase (PI3K). PIP3 acts as an second messenger to activate protein kinase B (PKB), 





Rab protein is a key regulator of various membrane trafficking events which 
belongs to the small GTPase family. (Pfeffer 2005) The Rab family comprises more than 
70 members, each of which has specific intracellular localization and controls a 
determined vesicular transport pathway, such as endocytosis, protein trafficking, 
endosome fusion, exocytosis. (Pfeffer 2005) By far, only a small fraction of Rab protein 
functions have been identified. Rab proteins facilitate transport along the cytoskeleton 
and participate in fusion and docking. Rab proteins cycle between an active and an 
inactive state (Pfeffer 2005). Binding of GTP to Rab stimulates its function whereas 
association with GDP inactivates it. (Pfeffer 2005) Guanine nucleotide exchange factors 
(GEF) exchange GDP for GTP to generate the active Rab GTP form, whereas GTPase 
activating proteins (GAP) generate the inactive Rab-GDP form. (Pfeffer 2005) 
 
At the beginning of internalization, ligands are sequestered into clathrin coated 
pits. Rab5 is localized to the membrane, early endosomes and clathrin coated vesicles. 
Endocytosis of internalized extracellular molecules is initiated by Rab5 (Christoforidis, 
 
9 
McBride et al. 1999), which directs plasma membrane derived vesicles to Rab4 positive 
early endosomes. Molecules can be then recycled back to the plasma membrane from the 
early endosome via two pathways: a fast direct route that depends on Rab4, and a slow 
route via Rab11 positive late recycling endosomes. (Chen, Feng et al. 1998) Rab11 
mediates intracellular vesicle trafficking that delivers plasma membrane proteins from the 
Golgi complex to the cell surface along actin filaments (Chen, Feng et al. 1998). Rab4 
controls the rapid recycling of cargo proteins directly back to the cell membrane 
(D'Souza, Semus et al. 2014). BKα protein is trafficked in Rab4A-mediated endosomes 
to the plasma membrane in myocytes. (Leo, Bulley et al. 2015) Rab25 protein has been 
found to regulate surface expression of Cav 1.2 channel in arterial myocytes. (Bannister, 
Bulley et al. 2016) 
 
 
Stroke-prone Spontaneously Hypertensive Rat 
 
The stroke-prone spontaneously hypertensive rat (SP-SHR) is a typical genetic 
model for studying hypertension and cerebral stroke. SP-SHRs were bred from a strain of 
spontaneously hypertensive rats in 1963 by Okamoto et al. (Okamoto and Aoki 1963) 
The third generations of hypertensive rats developed 80% incidence of stroke as well as 
hypertension (180-200 mmHg). (Okamoto and Aoki 1963) The pathological finding of 
cerebral stroke in SP-SHR does not lie on atherosclerosis which results in impaired brain 
perfusion and cerebral infarction. (Nabika, Cui et al. 2004) Instead, the 
pathophysiological mechanism of SP-SHRs might be that malignant hypertension leads 
to brain edema and lacunar infarction. (Nabika, Cui et al. 2004)  
 
It has been reported that lower expression of β1 protein reduced the Ca2+ 
sensitivity of BK channels in arterial smooth muscle cells of SP-SHRs compared with SD 
rats. (Amberg and Santana 2003) This could explain why mean blood pressure increased 
in SP-SHR compared with SD rats. But the expression of β1 protein did not have 
statistically difference between WKY and SP-SHR. (Amberg and Santana 2003) Previous 
studies indicated that NADPH oxidase is elevated in various tissue of SP-SHRs. 
(Chabrashvili, Tojo et al. 2002, Panico, Luo et al. 2009) Superoxide was produced by 
NADPH oxidase (NOX) in the kidney of SP-SHR. (Chabrashvili, Tojo et al. 2002, 
Panico, Luo et al. 2009) Elevated expression of NADPH oxidase 3 was also found in the 
cerebrum of SP-SHRs. (Nozoe, Hirooka et al. 2007, Michihara, Oda et al. 2016) 
Increased NADPH oxidase generates reactive oxygen species in tissues of SP-SHRs. 
(Amberg, Bonev et al.) Elevated reactive oxygen species (Amberg, Bonev et al) degrade 
free NO into ONOO-, therefore decrease NO level. Vascular smooth muscle cells of rats 
exposed to oxidative stress (H2O2) results in dose- and time- dependent activation of 
PKC. (Li, Maasch et al. 1999) Imidapril, an angiotensin converting enzyme inhibitor, 
prevented the incidence of stoke in SP-SHRs. (Ogiku, Sumikawa et al. 1993) So 
increased reactive oxygen species may be one of underlying mechanisms to induce 









The large-conductance Calcium (Ca2+)-activated potassium channel (BK channel) 
plays a vital role in maintaining the dynamic regulation between vasoconstriction and 
vasodilation of the vascular smooth muscle. The stimulators of BK channel include 
membrane depolarization and elevation of intracellular Ca2+. Previous studies have 
focused on the open probability and single channel current of BK channels regulated by 
protein kinases. But the mechanism how protein kinases regulate the number of 
functional channels on the cell membrane is not well understood. Previous common 
concept is that all channel subunits are assembled completely before trafficked to cell 
surface. Previous data shows that regulatory β1 subunits resided predominantly inside the 
cell and were rapidly trafficked to cell membrane and associated with α subunits by 
activation of Protein Kinase G (PKG) or Protein Kinase A (PKA) (Leo, Bannister et al. 
2014). However, the regulation of β1 subunit trafficking by Protein Kinase C (PKC) 
pathway is not known. We hypothesize that activation of PKC can reduce PKG-induced 







Specific aim 1  
 
The membrane current (I) generated by a population of ion channels, such as BK, 
is determined by their open probability (Po), the number of channels (N) and single 
channel current (i).(Leo, Bannister et al. 2014) Recent evidence indicates that in resting 
arterial myocytes, only a small proportion of total β1 subunits are present at the plasma 
membrane, with most β1 protein located intracellularly within Rab11A-positive recycling 
endosomes.(Leo, Bannister et al. 2014) NO stimulates rapid (<1 min) protein kinase G 
(PKG)-mediated surface trafficking of intracellular β1 subunits, which associate with 
BKα to increase apparent Ca2+-sensitivity, thereby elevating open probability. (Leo, 
Bannister et al. 2014) Stimulated β1 subunit trafficking in myocytes is a principal 
mechanism by which NO promotes cerebral vasodilation. (Leo, Bannister et al. 2014) 
Membrane depolarization also activates BK channels by stimulating Rho kinase-
mediated β1 subunit trafficking in human and rat arterial myocytes. (Leo, Zhai et al. 
2017) It is unclear whether vasoconstrictors inhibit BK channels and stimulate 
contraction by reducing the surface abundance of β1 subunits and their association with 
BKα. If such mechanisms exist, it would be important to determine the processes by 
which vasoconstrictors decrease surface levels of β1. 
 
Previous data shows that sodium nitroprusside (SNP), a vasodilator that releases 
nitric oxide to activate PKG pathway, increased β1 subunits trafficking to surface more 
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than two-fold. We plan to focus on endothelin-1 (ET-1), which is a potent vasoconstrictor 
synthesized by endothelial cells. We hypothesize that ET-1 can reduce SNP-induced β1 
subunits trafficking to cell membrane. Localization of two subunits on the surface 
membrane or in the intracellular compartment can be determined by surface biotinylation 
and western blotting. We will also evaluate the localization and spatial proximity 
between α and β subunits by immunoFRET microscopy.  
 
ET-1 activates several signaling pathways in vascular smooth muscle cell, 
including PKC, MAPK and PKB pathways. We hypothesize that endothelin-1 reduces 
SNP-induced β1 subunits trafficking to cell membrane via PKC pathway. 
Bisindolylmaleimide-1 (BIM-1) acts as a competitive inhibitor for the ATP binding site 
of PKC and shows high selectivity for PKCα-, β1-, β2-, γ-, δ-, and ε-isozymes. We plan 
to test if BIM-1 can abolish the reduction of β1 subunits trafficking to surface by 
inhibiting PKC pathway. Surface biotinylation and immunoFRET microscopy will be 
performed to test the hypothesis. 
 
To evaluate the effects of vasoconstrictor on the physiological function of BK 
channels, we will perform inside-out patch clamp to determine whether endothelin-1 can 
decrease SNP-induced elevation of BK channel open probability via PKC pathway. We 
also plan to perform perforated patch clamp to determine whether endothelin-1 can 
reduce the frequency and amplitude of spontaneous transient outward currents (STOCs) 
of BK channel via PKC pathway. 
 
Physiological functions of endothelin-1 can be measured by using cannulated 
arteries pressurized at 60 mmHg. We plan to perform pressurized cerebral artery diameter 
measurements to examine whether endothelin-1 can inhibit SNP-induced vasodilation by 
inhibiting β1 subunits trafficking to cell membrane. We also expect that BIM-1 can 
decease endothelin-1 induced vasoconstriction.  
 
 
Specific aim 2  
 
Previous data shows that Rab11A was co-localized with β1 subunits in the highly 
mobile Rab11A positive recycling endosome in smooth muscle cells. The smooth muscle 
cells transfected with dominant negative Rab11A S25N failed to respond to PKG 
stimulation. We hypothesize that PKC may phosphorylate different sites of Rab11A to 
inhibit anterograde trafficking of β1-containing Rab11A recycling endosome. 
Bioinformatics analysis displays that there are 17 probable phosphorylation sites in 
Rab11A, of which Ser177 has the highest probability (Pavarotti, Capmany et al. 2012). 
We hypothesize that PKC phosphorylates Ser177 which inhibits Rab11A function of 
regulating trafficking.  
 
We plan to transfect smooth muscle cells with dominant negative Rab11A S177A 
and test whether PKC fails to inhibit Rab11A S177A endosome anterograde trafficking. 
We also plan to inside-out patch clamp to test whether Rab11A S177A alters ET-1 
inhibition of BK channel activity. Furthermore, we plan to perform pressurized cerebral 
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Specific aim 3  
 
BKα and β1 surface and total protein, cellular distribution, spatial proximity, and 
association (co-IP) will be measured in SP-SHR arteries. Regulation of these BKα and β1 
properties by vasodilators (NO donors) and membrane potential (by elevating [K+]o) will 
be examined. Pressurized hypertensive rat cerebral arteries are depolarized. Intracellular 
signaling pathways will be studied to identify pathological changes in mechanisms that 
control BKα and β1 subunit surface expression. Rab11A protein will be measured. 
Immunofluorescence and immune-FRET will measure colocalization and spatial 
proximity of BKα and β1 subunits to each other, Rab proteins. If expression of a Rab 
protein is reduced, we will overexpress that wild-type Rab in arteries and determine if 
pathological BKα and/or β1 trafficking or degradation is reversed.  
 
BK channel properties, and regulation by lithocholate will be measured in 
myocytes of WKY and hypertensive rats. Experiments would be investigated altered 
intracellular signaling pathways and Rab proteins that underlie dysfunctional regulation 
of BK channel subunits by vasodilators and membrane depolarization. Endothelium-
denuded arteries will be studied. Responses to lithocholate and following exposure to NO 













Male Sprague-Dawley rats (7-8 weeks) or male WKY rats (6 weeks), male SP-
SHR (6 weeks) were purchased from Harlan-Teklad Laboratories (Ewing, IL). All 
experiments were conducted ex vivo. We conducted the research in accordance with the 
Guide for Care and Use of Laboratory Animals. The Animal Care and Use Committee 






All euthanasia protocols were approved by IACUC. Male Sprague-Dawley rats 
(7-8 weeks) were knocked down with carbon dioxide directly introduced into a special 
chamber. Rats were euthanized with intraperitoneal injection of sodium pentobarbital 
(150mg/kg) (Vortech Pharmaceuticals, Dearborn, MI). New needles and syringes were 
used each time to avoid additional trauma. All efforts were done to reduce distress to rats 
during the euthanasia procedure. The method was followed according to euthanasia 
recommendations from the American Veterinary Medical Association Panel. Sodium 
pentobarbital was used to induce sedation, followed by unconsciousness. Animal 
euthanasia was confirmed by loss of corneal reflex, minimum movement to skin pinch, or 





The brain was removed, cleaned and placed in ice-cold HEPES-buffered 
physiological saline solution containing (in mmol/L): 134 NaCl, 6 KCl, 2 CaCl2, 1 
MgCl2, 10 HEPES, and 10 glucose (pH 7.4). Cerebral arteries (anterior cerebral, middle 
cerebral, posterior cerebral, cerebellar, basilar) were dissected from the brain. Cerebral 
arteries were carefully cleaned from brain tissue and connective tissue under microscope 
(Nikon), preventing the arteries from any stretch or damage. The cleaned arteries were 





Isolation of Arterial Smooth Muscle Cells 
 
 
Preparation of solutions used for smooth muscle cell isolation 
 
Isolated cerebral arteries were placed for in a Ca2+- free whole cell buffer solution 
containing (in mM): 55 NaCl, 5.6 KCl, 80 sodium glutamate, 2 MgCl2, 10 HEPES, and 
10 glucose (with pH adjusted to 7.4 with NaOH). Three glass vials were rinsed and 
washed with distilled water. Papain (0.7 mg/ml, Sigma), dithioerythreitol (1mg/ml) and 
bovine serum albumin (BSA) (1 mg/ml) were dissolved in Ca2+- free solution. 
Collagenases F (0.7 mg/ml) and collagenase H (0.3 mg/ml) were added to Ca2+- free 
solution. Before isolation, collagenase solution was supplemented with CaCl2 (100 μM). 
Papain and collagenase solutions in vials were warmed in 37°C water bath for 10 minutes 
before transferring cerebral arteries into the vials.  
 
 
Freshly dissociated cerebral arteries 
 
When papain solution in vial was warmed, cerebral arteries were placed into the 
vial and incubated for 12.5 minutes in 37°C water bath. Next, the arteries were promptly 
transferred to pre-warmed collagenase solution and incubated for 7 minutes in 37°C 
water bath. Incubation time was adjusted to 15 mins for papain and 9 mins for 
collagenase when more myocytes were needed to be isolated from cerebral arteries. After 
collagenase digestion, cerebral arteries were subsequently transferred in a vial and 
washed by ice-cold Ca2+-free solution for three times to stop enzyme digestion. The 
rinsed arteries were transferred to another vial containing Ca2+-free solution and put on 
ice to settle down for 10 min. About 1ml Ca2+-free whole cell solution was added into 
vial which contained digested cerebral arteries. A special glass pipette was used to gently 
triturate the arteries up and down for ten times. No air bubbles was introduced into the 
solution otherwise the bubbles could harm the myocytes. Myocytes were gently 
dissociated from the arteries during the trituration process. Myocytes were ready for use 
within next 8 hours. 
 
 





Intact arteries were incubated in low binding vial containing 1 mg/ml EZ-Link 
Sulfo-NHS-LC-LC-Biotin and 1 mg/ml EZ-Link Maleimide-PEG2-Biotin reagents 
(Pierce) HEPES-buffered physiological saline solution containing for 1h at room 
temperature. Sodium nitroprusside (10 µM) was added at last 10 mins during the 
incubation. Endothelin-1 (10 nM) or BIM (20 µM) was added at the beginning of 
biotinylation at each condition. The vial containing intact arteries was centrifuged for 2 
mins at 6.0 rpm. The PSS containing biotin was removed by pipette. Free biotin was 
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quenched by washing the arteries in PBS with 100 mmol/L glycine for 15min. Arteries 
were then washed in PBS to remove any residual glycine solution for 15min. Biotinylated 
arteries were homogenized in lysis buffer containing Tris 50mM, NaCl 150mM, EDTA 




Protein concentration estimation 
 
5 µL protein sample was added onto nitrocellulose membrane (Bio-Rad, CA) and 
dry before use. The nitrocellulose membrane was incubated with Amido black solution 
for 2 mins. Then, the membrane was washed by distilled water for 2mins. The membrane 
was then washed by the destained solution for 2 mins to wash off any residue Amido 
black. The membrane containing stained protein sample in glass tube was added with 1 
mL elute solution and incubated for 25min to dissolve the Amido black. The elute 






Total protein was pulled down with avidin (1:1.2, Thermos Scientific) for 1h in 
the cold room. After pulldown, the sample was centrifuged at 13,000g for 2 mins. 
Biotinylated proteins were bound to the avidin beads and the supernatant contained the 
nonbiotinylated (intracellular) protein fraction. The beads were washed 3 times with PBS, 
and Laemmli buffer was added to both the beads and intracellular protein lysate. Samples 
were then boiled for 3 minutes. Biotinylated surface proteins were eluted from the avidin 





Protein lysates were heated with 1× or 5× Laemmli buffer (Bio-Rad) for 3 mins. 
Protein was separated on 7.5% or 12% SDS-PAGE polyacrylamide gels. Molecular 
weight markers (Bio-Rad, Hercules, CA) were used in one lane to monitor protein 
progress on the gel. Gel was run in a chamber containing SDS running buffer (containing 
12g Tris, 57.6g Glycine and 3g SDS into total 4L distilled water) at 150 V for ~1h. The 
run was stopped when the lowest marker reached the bottom of gel.  
 
The gel was placed with nitrocellulose membrane (Bio-Rad, Hercules, CA) 
between two sponges and two filter paper in a binding cassette as a “transfer sandwich”.  
No bubbles were introduced between gel and membrane otherwise it would cause bald 
spots. The cassette was then placed into a chamber containing transferring buffer 
(containing 12g Tris, 57.6g Glycine and 800 ml methanol into total 4L distilled water). 
Proteins were transferred for 1.5h at 100 V using a Mini Trans Blot Cell (Bio-Rad, 




Blots were blocked with 5% nonfat dry milk or 5% BSA in Tris-buffered solution 
(TBS) added with 0.1% Tween-20 (TBS-T) at room temperature for 1h.  Membranes 
were then probed with mouse monoclonal anti-BKα (1:500 dilution, Neuromab, UC 
Davis), rabbit polyclonal anti-BKβ1 (1:500, Abcam), rabbit monoclonal anti-rab11A 
(1:500, Cell Signaling), rabbit polyclonal anti-phosphoserine (1:500, Millipore) or mouse 
monoclonal anti-active rab11 (1:500, NewEast Biosciences) antibodies overnight at 4°C.  
 
The blots were incubated with primary antibodies overnight in cold room. Then 
the blots were washed with TBS-T for 6 times 10min each. Then the blots were incubated 
with horseradish peroxidase-conjugated secondary antibodies (mouse or rabbit) in 5% 
nonfat dry milk for 1h at room temperature. After that, the blots were washed 6 times 
with TBS-T. The membranes were exposed to reagents from a chemiluminescent 
detection kit (supersignal west femto pierce, Thermo Scientific). The blots were imaged 
with a Kodak In Vivo F Pro Imaging System or Bio-Rad ChemiDoc Touch imaging 
system. Band intensity was quantified using Quantity One software (Bio-Rad). 
Membranes were developed using different exposure time in order to optimize band 
intensity.  
 
Using Restore Western Blot Stripping Buffer (Thermo), the blots were stripped 
for 5-10 mins at room temperature. The blots were then washed with TBS-T twice and re-
blocked with 5% nonfat dry milk in Tris-buffered solution for 1h. The blots were then 
ready for re-probing with other indicated antibodies. Band intensity was quantified using 
Quantity one software (Bio-Rad, Hercules, CA). The band density was calculated by 
placing a rectangular box around the band, which then subtracted with background 
density with the same size of the box. Average band density was calculated from images 
of different exposure time. The band density of a specific protein was normalized with 
that of the loading control protein actin or cytochrome C. 
 
 
Immunofluorescence and Immuno-FRET Microscopy 
 
Isolated myocytes were exposed to agents and then were plated on poly-L-lysine-
coated coverslips. Cells were fixed with 3.7% paraformaldehyde and permeabilized with 
0.1% Triton X-100. Cells were blocked with 5% bovine serum albumin (BSA) and then 
incubated with mouse monoclonal anti-BKα (Neuromab, UC Davis) and rabbit 
polyclonal anti-BKβ1 (Abcam) antibodies overnight at 4°C. After washing with PBS, 
cells were incubated for one hour with Alexa 546- or Alexa 488-conjugated secondary 
antibodies (1:100 dilution; Life Technologies). After washing, coverslips were mounted 
onto slides with 1:1 glycerol: PBS media. Fluorescence images were acquired using a 
laser-scanning confocal microscope (LSM5 Pascal; Carl Zeiss). Alexa 488 and Alexa 546 
were excited at 488 and 543 nm, and emission was collected at 505-530 and ≥560 nm. 
For N-FRET analysis, images were background-subtracted and N-FRET calculated on a 
pixel-by-pixel basis using the Xia method (Xia and Liu 2001) and Zeiss LSM FRET 







Transformation of competent cells 
 
Competent GC10 bacterial cell (50 µg, Sigma-Aldrich, St. Louis, MO) were used 
for transformation. Vectors (>20ng) were added to GC10 cells and incubated on ice for 
15 mins. Competent cells were then heat shocked in a water bath at 42ºC for 45 seconds. 
The cell membrane was permeabilized by the heat shock which allowed vectors enter the 
cells. After heat shock, the cells were placed on the ice. Transformed cells were plated 
onto ampicillin (100 μg/ml) resistant LB plates beside Bunsen burner. Agar plates were 
then incubated at 37 °C overnight. Bacteria which have expressed vectors containing 





A single bacterial colony which expressed vectors was inoculated into LB broth 
supplemented with ampicillin (100 μg/ml) and incubated at 37°C at 200 rpm overnight. 
Plasmid cDNA was extracted and purified from the bacteria using Qiagen Maxiprep 
HiSpeed Plasmid Purification kit (Qiagen, Valencia, CA). 
 
LB broth was made and autoclaved in a 1L flask. After LB broth was cool, 50 
mg/ml ampicillin was added into the LB broth. A bacterial colony was picked and put 
into LB broth besides the Bunsen burner. The flask was incubated in 37oC incubator 
overnight. On the next day, LB broth was put into plastic centrifuge bottle and then 
centrifuged for 15 mins at 5000 rpm. The supernatant was gently poured off and bacterial 
pellet was re-suspend in 10 ml Buffer P1 on ice. The re-suspended pellet solution was 
transferred to a plastic centrifuge tube. 10 ml Buffer P2 was added into tube and mixed 
gently. The mixed solution was incubated at room temperature for 5 minutes. Then 10 ml 
of cold Buffer P3 was added and mixed immediately but gently by inversion. The 
solution was incubated on ice for 20 minutes and then centrifuged for 30 mins at 12,000 
rpm at 4oC. During the last 10 mins of the spin, Qiagen-tip 500 column was equilibrated 
by adding 10 ml Buffer QBT. The supernatant was decanted in Falcon 50ml tubes. 
Decanted supernatant was added to column. The column was washed twice with 30 ml 
Buffer QC. The DNA was eluted by adding 5 ml Buffer QF. The DNA was precipitated 
with 7 ml room-temperature isopropanol. The precipitated DNA was centrifuged for 30 
mins at 12,000 rpm at 4oC. The supernatant was poured off and then 5 ml 70% ethanol 
was added into the tube. The tube was centrifuged for 5 min at 12,000 rpm at 4oC. The 
supernatant was poured off. The DNA was dried for 5 min in the air and then re-





Transfection of Intact Cerebral Arteries 
 
A Rab11A sequence with a serine 177-to-alanine mutation (Rab11A S177A) was 
generated and sub-cloned into pcDNA3.1(+) (GenScript USA Inc., Piscataway, NJ). 
Empty pcDNA3.1 vectors, pcDNA3.1 encoding Rab11A, or pcDNA3.1 encoding 
Rab11A S177A were transfected into arteries using electroporation (CUY21Vivo-SQ 
electroporator; Bex), as previously described. (Narayanan, Bulley et al. 2013) Cerebral 
arteries were placed in an electroporation chamber containing Ca2+- free PBS with either 
Rab11A WT, Rab11A S177A or empty vectors. Tandem-pulse electroporation was 
applied to cerebral arteries eight times in the chamber. The pulse voltage was set at 50 
mV. On-time application was set for 50 ms. Arteries were then placed in serum-free 
DMEM-F12 media supplemented with 1% penicillin-streptomycin for 3 days before use. 
 
 
HEK293 Cell Culture and Transfection 
 
Human Embryonic Kidney 293 cells (HEK293, ATCC, Manassas, VA) were 
maintained in DMEM supplemented with 10% fetal bovine serum (FBS, Cellgro, 
Manassas, VA) and 1% penicillin-streptomycin under standard culture conditions (21% 
O2-5% CO2; 37°C). Cells were transiently transfected with pcDNA3.1(+) encoding full-
length β1 (2 μg) or empty vector (2 μg) using Effectene transfection kit (Qiagen). 
HEK293 cells were cultured on sterile petri dishes in a 74% N2/21% O2/5% CO2 
incubator to achieve confluency. Cells were lysed after 48 hours post-transfection. 
Protein concentration was calculated as previously described. Cell lysates were run on 





Protein lysate was harvested from cerebral arteries from six rats using ice-cold 
radio-immunoprecipitation buffer. Proteins were pulled down from arterial lysate using 
the Catch and Release version 2.0 immunoprecipitation kit (Millipore) per the 
manufacturer’s instructions. Concentrated wash buffer was diluted into the 1× 
concentration with water for incubation and following washes. The spin columns, 
centrifuge tubes and capture tubes were labeled to be used. The snap-off bottom plug was 
removed and the spin column was inserted into a capture tube. The screw-on cap was 
removed and centrifuged at 5000 rpm for 15s to remove the resin buffer. The resin was 
washed twice with 400µl 1× wash buffer. The capture tube was emptied and the bottom 
end of the column was plugged with the snap-off bottom plug. 
 
Samples were incubated with Rab11A primary antibody, 0.5ml capture resin and 
10µl antibody affinity ligand in columns at 4oC overnight. The columns were centrifuged 
at 5000 rpm and the flow through discarded. The capture resin was washed with 1X wash 
buffer twice. Bound proteins were released using denaturing buffer and then boiled for 3 
mins. Protein samples were analyzed using Western blotting with anti-rab11A (1:500, 
Cell Signaling). The blots were stripped using Restore Western Blot Stripping Buffer 
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Single BK channels or transient BK currents were recorded in isolated myocytes 
using the inside-out or perforated patch-clamp configurations, respectively. Currents 
were recorded by an Axopatch 200B amplifier and Clampex 10.3. For inside-out patch-
clamp, myocytes were allowed to settle in a recording chamber before exposure to 
combinations of ET-1 (1 hour), BIM (1 hour) and SNP (10 min) prior to patch excision. 
Inside-out patches were pulled and agents were washed out so that channel activity was 
measured in the absence of these agents using a holding potential of -40mV or +80mV. 
For inside-out recordings, the pipette and bath solution both contained (in mmol/L): 130 
KCl, 10 HEPES, 5 EGTA, 1.6 HEDTA, 1 MgCl2, and 10 μmol/L free Ca
2+ (pH 7.2).  
 
 
Perforated whole cell patches 
 
Transient BK currents were measured using the amphotericin B perforated patch 
configuration at a steady voltage of -40mV. For perforated patch-clamp, the bath solution 
contained (in mmol/L): 134 NaCl, 6 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, and 10 glucose 
(pH 7.4) and the pipette solution contained (in mmol/L): 110 potassium aspartate, 30 
KCl, 10 NaCl, 1 MgCl2, 10 HEPES, and 0.05 EGTA (pH 7.2). Currents were filtered at 1 




Pressurized Artery Myography 
 
Artery segments (1-2 mm length) were cannulated in a perfusion chamber (Living 
Systems Instrumentation, St. Albans, VT) and continuously perfused with 37 ºC 
physiological saline solution (PSS) which contained: 112 NaCl, 4.8 KCl, 24 NaHCO3, 
1.8 CaCl2, 1.2 MgSO4, 1.2 KH2PQ4 and 10 glucose, gassed with mixture of 21% O2, 5% 
CO2 and 74% N2. The endothelium was denuded by introducing an air bubble into the 
lumen for ~1 minute followed by wash with PSS. The procedure was carefully performed 
in order to avoid any stretch or damage to the arteries. Artery segments without any small 
branches were chosen to be cannulated in the chamber. If there were any small branches, 
they were tighten with thread. The chamber containing artery segment was placed on the 
stage of a Nikon TS100-F microscope. Intravascular pressure was achieved by raising a 
water-filled reservoir which was connected to the cannulated arteries. The pressure was 
monitored using a pressure transducer. Arterial diameter was measured using a CCD 
camera attached to a Nikon TS100-F microscope. The diameter changes were measured 
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in real time by the edge-detection function of IonWizard (Ionoptix, Milton, MA). The 
chamber was constantly perfused with PSS, or PSS containing indicated agents. 
Myographic traces were analyzed using IonWizard software. Myogenic tone (%) was 
calculated as: 100 × (1 – Dactive/Dpassive), where Dactive is active arterial diameter and 
Dpassive is the diameter determined in Ca
2+-free PSS supplemented with 5 mmol/L EGTA. 
 
 
Reagents and Chemicals 
 
Sodium nitroprusside was purchased from Sigma-Aldrich Company (St. Louis, 
MO). Endothelin-1 was also purchased from Sigma-Aldrich Company (St. Louis, MO). 





Statistical analyses were performed using GraphPad Prism v4.0 and Origin v6.0. 
Values are presented as mean ± SEM. Student’s t-test with two tail p value was used to 
compare paired and unpaired data from two populations. ANOVA with Student-
Newman-Keuls post hoc test was used for multiple group comparisons. The values were 
assumed to be sampled from a Gaussian distribution. P < 0.05 was considered significant. 





CHAPTER 4.    RESULTS* 
 
 
ET-1 Inhibits NO-induced Surface Trafficking of Β1 Subunits via PKC Activation 
 
To measure the cellular distribution of BKα and β1 subunits in myocytes of intact 
arteries, we used biotinylation, a method previously validated to label surface, but not 
intracellular proteins. (Bannister, Adebiyi et al. 2009, Kidd, Bulley et al. 2016)  
 
Our data indicated that BKα subunits were primarily present in the plasma 
membrane, whereas β1 was mostly intracellular in resting resistance-size cerebral arteries 
(Figure 4-1A, D). ET-1 alone did not change the surface abundance of either BKα or β1 
subunits (Figure 4-1B). To further study ET-1-modulation of subunits, sodium 
nitroprusside (SNP), a NO donor, was first applied to stimulate surface trafficking of β1, 
as previously demonstrated.(Leo, Bannister et al. 2014) SNP increased surface β1 protein 
~2.6-fold, but did not alter surface BKα protein (Figures 4-1A, 4-2B). ET-1 inhibited the 
SNP-induced increase in surface β1 protein (Figures 4-1A, 4-2B). Changes in surface β1 
were associated with corresponding shifts in intracellular β1, suggesting β1 protein 
redistributed from an intracellular compartment to the surface (Figure 4-2B, C). SNP and 
ET-1 did not alter total β1 protein, indicating that β1 subunits were not degraded (Figure 
4-2B, C). SNP and ET-1 did not alter BKα distribution or total protein (Figures 4-1D,  
4-2D). These data suggest that ET-1 inhibits NO-induced surface trafficking of β1 
subunits in arterial myocytes.  
 
Many vasoconstrictors, including ET-1, stimulate Gq/11 in myocytes, leading to an 
increase diacylglycerol, which activates protein kinase C (PKC).(Ivey, Osman et al. 2008, 
Wynne, Chiao et al. 2009) To examine mechanisms by which ET-1 decreased β1 subunit 
trafficking, bisindolylmaleimide (BIM, 1h), a PKC inhibitor, was used. BIM abolished 
the ET-1-induced inhibition of β1 subunit surface trafficking, essentially restoring SNP-
induced stimulation of surface β1 protein (Figure 4-1A, D). In contrast, BIM did not alter 
surface β1 protein when applied alone (Figure 4-1C). BIM also did not change surface 
BKα when applied alone or together with ET-1 (Figure 4-1C). These data suggest that 




β1 Antibody Identifies HEK Cell Expressing β1 Subunits 
 
  In order to test β1 antibody identified β1 protein, HEK293 cells were transfected 
with pcDNA3.1-empty vectors or pcDNA3.1-BK β1 vectors and then cultured for three 
days. The total protein lysate was obtained from two groups of cultured HEK293 cells 
 
--------------- 
* Portions of this chapter adapted with permission. Zhai, X., M. D. Leo and J. H. Jaggar 
(2017). "Endothelin-1 Stimulates Vasoconstriction Through Rab11A Serine 177 





Figure 4-1. ET-1 decreases NO-induced surface trafficking of β1 subunits via 
PKC activation. 
 
Notes: (A) Representative Western Blots indicating surface (S) and intracellular (I) BKα 
and β1 subunits. Rat cerebral arteries were exposed to: nothing (control), SNP (10 
µmol/L, 10 min), SNP (10 µmol/L, 10 min) +ET-1 (10 nmol/L, 1h) or BIM (20 µmol/L, 
1h)+ SNP (10 µmol/L, 10 min) + ET-1 (10 nmol/L, 1h). (B) Representative Western 
Blots indicating surface (S) and intracellular (I) BKα and β1 subunits. Rat cerebral 
arteries were exposed to: nothing (control) and ET-1 (10 nmol/L, 1h) only. (C) 
Representative Western Blots indicating surface (S) and intracellular (I) BKα and β1 
subunits. Rat cerebral arteries were exposed to: nothing (control), BIM (20 µmol/L, 1h) 
only and BIM (20 µmol/L, 1h) +ET-1 (10 nmol/L, 1h). (D) Mean data illustrating BKα 
and β1 subunit protein distribution (= Surface protein / Total protein) (n=6 for each). 





Figure 4-2. SNP, ET-1, BIM, or combination of these agents do not change total 
protein of BKα and β1 subunits after surface biotinylation. 
 
Notes: (A) Mean surface protein data from biotinylation experiments (n=6 for each). 
*p<0.05 vs. control, # p<0.05 vs SNP, † p<0.05 vs. ET-1+SNP. (B) Mean data for 
intracellular β1 and BKα protein (n=6 for each). *p<0.05 vs. control, # p<0.05 vs. SNP, † 
p<0.05 vs. ET-1+SNP. (C) Mean data for total β1 protein compared to control (n=6 for 




and run on Western blotting. The β1 antibody did not identify a protein in lysate from 
mock-transfected HEK293 cells, but identified a ~34 kDa protein in cells expressing 
recombinant β1, which was of a similar molecular mass to that of arterial β1 protein 
(Figure 4-3).  
 
  These experiments provide additional support for previous evidence that the 
biotinylation procedure does not label intracellular proteins and that the β1 subunit 
antibodies detect β1 protein. 
 
 
ET-1 Inhibits Depolarization-induced Surface Trafficking of Β1 Subunits in 
Arterial Myocytes 
 
  Experiments were performed to investigate whether ET-1 inhibition of β1 subunit 
surface trafficking is specific to NO or a more general inhibitory mechanism. Membrane 
depolarization also stimulates an increase in surface β1 subunits, leading to BK channel 
activation.(Leo, Zhai et al. 2017) Membrane depolarization (30 mmol/L K+) increased 
surface β1 protein 3.70-fold, but did not alter surface BKα in cerebral arteries (Figure 
4-4A, B).  ET-1 inhibited the depolarization-induced increase in surface β1 protein 
(Figures 4-4A, B). BIM reduced the ET-1-induced inhibition of β1 subunit surface 
trafficking by ~ 60 % (Figure 4-4A, B). These data suggest that ET-1 stimulation of PKC 
inhibits both NO- and depolarization-induced surface trafficking of β1 subunits in arterial 
myocytes. 
 
  Control experiments were performed to examine both the arterial biotinylation 
procedure and the β1 subunit antibodies. Reprobing blots from arterial biotinylation 
experiments indicated that cytochrome C, a mitochondrial protein, was detected only in 
the intracellular (i.e. non-biotinylated) fraction (Figure 4-4A). There were no significant 
difference of cytochrome C expression among these group, indicating that the total 
among of protein was similar. 
 
 
ET-1 Decreases NO-induced N-FRET Between Β1 and Bkα Subunits via PKC 
Activation 
 
  Förster resonance energy transfer (FRET) imaging followed by N-FRET analysis 
was used to measure BKα and β1 subunit colocalization and spatial proximity in isolated 
cerebral artery myocytes. In control, the majority of BKα subunits were localized at the 
cell periphery, whereas β1 subunits were primarily intracellular. N-FRET between BKα 
and β1 subunit-bound secondary antibodies in control was low, as previously 
demonstrated (Leo, Bannister et al. 2014) (Figure 4-5A, B).  
  
  After myocytes were exposed to SNP (10μM, 10mins), SNP increased N-FRET 
~2.8-fold with FRET located at the cell surface (Figure 4-5A, B). It indicated that SNP 
induced surface trafficking β1 subunits, which associated with BKα subunits so that N-





Figure 4-3. Anti-β1 antibody only detects HEK293 cells transfected with BK β1 
vectors. 
 
Note: Representative western blotting indicating β1 protein and actin. HEK293 cells were 
transfected with empty vectors (left lane) or BK β1 vectors (right lane) and total protein 








Figure 4-4. ET-1 decreases depolarization-induced surface trafficking of β1 
subunits via PKC activation. 
 
Notes: (A) Representative Western Blots indicating surface (S) and intracellular (I) BKα, 
β1 and cytochrome C (cyt C). Arteries were exposed to: 6 mmol/L K+ (control), 30 
mmol/L K+ (10 min), ET-1 (10 nmol/L, 1h), and BIM (20 µmol/L, 1h) alone or in 
combinations indicated. (B) Mean surface protein data from biotinylation experiments 
(n=5 for each). *p<0.05 vs. control, # p<0.05 vs 30 mmol/L K+, † p<0.05 vs. 30 mmol/L 
K+ + ET-1. (C) Mean data illustrating BKα and β1 subunit protein distribution (n=6 for 








Figure 4-5. ET-1 decreases NO-induced N-FRET between β1 and BKα subunits 
via PKC activation. 
 
Note: (A) Representative immunofluorescence and immuno-FRET images of BKα and 
β1 in arterial myocytes. Scale bars, 10μm. SNP (10 µmol/L, 10 min), ET-1 (10 nmol/L, 
1h), BIM (20 µmol/L, 1h) were applied alone or in combinations indicated. (B) Mean 
data for BKα and β1 immuno-FRET (%). (n=10 for each) *p<0.05 vs. control, # p<0.05 




  To examine ET-1 inhibited the co-assembly between β1 and BKα subunits, 
myocytes were first exposed to ET-1 (10nM, 1h). SNP (10uM) was added at last 10 mins. 
Endothelin-1 reduced the N-FRET from 19% in the SNP group to about 6.8%, which 
means that ET-1 inhibited the ability of SNP to increase N-FRET. (Figure 4-5A, B) 
  
  In contrast, BIM restored N-FRET to about 17%, which demonstrated that the 
inhibitory effect was blocked by BIM (Figure 4-5A, B). These data suggest that ET-1 
activates PKC which inhibits β1 subunit surface trafficking, thereby blocking plasma 
membrane co-assembly of β1 with BKα subunits in arterial myocytes. 
 
 
ET-1 Inhibits NO-induced Po of BK Channels via PKC Pathway 
 
To investigate BK channel regulation by ET-1, patch-clamp electrophysiology 
was performed. Isolated arterial myocytes were exposed to nothing (control), SNP, ET-
1+SNP or SNP+ET-1+BIM. Inside-out patches were pulled from myocytes and agents 
washed out with bath solution to measure channel properties under the same experimental 
conditions and to remove any direct effects of pharmacological modulators on activity. 
BK channel activity was measured with 10 µM free intracellular Ca2+ concentration at 
either -40mV, a physiological voltage, or +80mV to stimulate maximal activation.  
 
In excised patches from control myocytes, mean BK channel open probability was 
~0.20 (Figure 4-6A, B). Myocytes were exposed to SNP for 10min. After inside out 
patches were pulled from myocytes, SNP were washed out. SNP treatment of myocytes 
increased BK channel mean Po to ~0.47, or ~2.35-fold (Figure 4-6A, B). Then the 
myocytes were treated with ET-1 for 1h before last 10mins SNP treatment. ET-1 reduced 
SNP-induced BK channel activation to ~40.0% of that stimulated by SNP alone (Figure 
4-6A, B). BIM blocked the ET-1-induced reduction in BK channel Po (Figure 4-6A, B).  
 
SNP, ET-1+SNP or BIM+ET-1+SNP did not alter BK channel maximal Po or the 
mean number of channels in patches (1.3±0.2, 1.5±0.3, 1.2±0.2, 1.3±0.3 channels in 
control, SNP, ET-1+SNP, BIM+ET-1+SNP, respectively; p>0.05) (Figure 4-6A, B). 
When combined with the biochemical data here, these data indicate that ET-1 activates 




NO Stimulates Active Rab11 and ET-1 Inhibits Active Rab11 
 
NO stimulates Rab11A-positive recycling endosomes to deliver β1 subunits to the 
plasma membrane.(Leo, Bannister et al. 2014) Cerebral arteries were exposed to nothing 
(control), SNP (10 µmol/L) or SNP (10 µmol/L) + ET-1 (10 nmol/L). Total protein 
lysates were obtained and run on Western blotting. To examine the molecular mechanism 
by which ET-1 stimulated-PKC inhibits β1 trafficking, we measured Rab11A activation 






Figure 4-6. ET-1 inhibits BK channels via a PKC-dependent mechanism. 
 
Notes: (A) Fresh, isolated arterial myocytes were exposed to nothing (control), SNP (10 
µmol/L), ET-1 (10 nmol/L) + SNP (10 µmol/L), or BIM (20 µmol/L) + ET-1 (10 nmol/L) 
+ SNP (10 µmol/L) after which inside-out patches were pulled and BK channel activity 
recorded in the absence of the agents. Representative traces illustrate BK channel activity 
recorded in 10μM free Ca2+ in the same patches at -40mV or +80mV. (B) Mean BK 
channel Po values obtained from fresh-isolated myocytes at -40mV and +80mV. (n=6 for 
each) *p<0.05 vs. control, # p<0.05 vs SNP, † p<0.05 vs. ET-1+SNP. & p<0.05 vs. ET-





Rab11-GTP, but not Rab11-GDP. SNP increased active Rab11 ~2.62 fold (Figure  
4-7A, B). ET-1 reduced active Rab11 to ~28.4% of that in SNP alone (Figure 4-7A, B). 




ET-1 Inhibits Rab11A Through Phosphorylation at Serine 177 
 
 
Bioinformatics study showed that Serine 177 in Rab11A has highest probability of 
phosphorylation by PKC 
  
  The mechanism by which PKC reduces Rab11A activity may occur either directly 
or indirectly through other signaling intermediates. We tested the hypothesis that PKC 
directly phosphorylates Rab11A to reduce activity. Analysis of the Rab11A amino acid 
sequence (NetPhosK 1.0) revealed five potential PKC phosphorylation sites, of which 
Ser177 had the highest probability (Table 4-1). We constructed a Rab11A S177A mutant 
to study physiological functions of serine 177 in β1 subunit trafficking. Basically, the 
codon which stands for Ser177 was mutated in to alanine by using site directed 
mutagenesis. The wild type rat’s Rab11A cDNA or Rab11A S177A cDNA was sub-
cloned into pcDNA3.1+. Our strategy is that we simply mutated one base pair so that it 
can conserve the function of protein as much as possible.  We mutated TCT (serine) 
into GCT (alanine). By using site directed mutagenesis, the basic idea is that the forward 
and backward primers are designed that containing the mutant base pair. During 
performing thermal cycling, mutant primers can also anneal to the wild type Rab11A 
plasmids and then synthesize Rab11A S177A. Then we transformed the plasmids into 
competent cells to generate more plasmids. 
 
 
Rab11A WT or Rab11A S177A similarly increases the total protein of Rab11A 
 
  To investigate the hypothesis that ET-1 phosphorylates Rab11A S177, cerebral 
arteries were transfected with vectors encoding either wild-type Rab11A (Rab11A WT) 
or Rab11A S177A. Cerebral arteries were cultured and then homogenized to get protein 
lysate. The total protein lysate was run on Western Blotting and total Rab11A protein 
was compared among three groups. Vectors encoding wild-type Rab11A or Rab11A 
S177A similarly increased total Rab11A protein, to ~190% of mock controls (Figure  
4-8A, B). Rab11A WT or Rab11A S177A did not alter levels of BKα, β1 or actin 







Figure 4-7. NO stimulates active Rab11, ET-1 inhibits active Rab11. 
 
Notes: (A) Representative Western Blots of active Rab11 and total Rab11A, BKα, β1 and 
actin in control arteries and arteries treated with SNP (10 µmol/L, 10 min) or SNP + ET-1 
(10 nmol/L, 1h). (B) Mean data of active Rab11 in SNP and SNP+ET-1 group compared 





Table 4-1. Potential PKC phosphorylation sites in Rab11A, of which S177 has 
the highest probability. 
 
Site Kinase Score 
T-59 PKC 0.70 
S-78 PKC 0.53 
T-170 PKC 0.57 
S-177 PKC 0.75 









Figure 4-8. Rab11A WT or Rab11A S177A similarly increases total Rab11A 
protein. 
 
Notes: (A) Representative Western Blots probed for total Rab11A, BKα, β1 or actin 
protein in arteries transfected with either an empty vector (mock) or a vector encoding 
Rab11A WT or Rab11A S177A. (B) Mean data of Rab11A total protein in Rab11A WT 





Anti-Phosphoserine Is Increased in ET-1-treated Cerebral Arteries Expressing 
Rab11A WT but Not Rab11A S177A 
 
  Cerebral arteries were transfected with Rab11A or Rab11A S177A and cultured 
for three days. Arteries expressing either wild-type Rab11A or Rab11A S177A were 
exposed to ET-1 or nothing (control). Then, Rab11A protein was pulled down from total 
protein lysate and run on Western blots.  
 
  ET-1 did not alter the amount of total Rab11A in arteries expressing either wild-
type Rab11A or Rab11A S177A (Figure 4-9A, B, C). Reprobing blots with an anti-
phosphoserine antibody indicated that in the absence of ET-1, basal Rab11A 
phosphorylation was similar in arteries expressing either Rab11A WT or Rab11A S177A 
(Figure 4-9A, B, C). ET-1 increased Rab11A phosphorylation ~227 % in arteries 
expressing wild-type Rab11A. In contrast, ET-1 increased Rab11A phosphorylation only 
~138 % in arteries expressing Rab11A S177  or ~60 % of that in ET-1-treated arteries 
expressing Rab11A WT (Figure 4-9A, B, C). These data indicate that ET-1 
phosphorylates serine 177 in Rab11A, leading to Rab11A inhibition in arterial myocytes. 
 
 
ET-1 Inhibits β1 Subunit Surface Trafficking Through Rab11A Serine 177 
 
Experiments were performed to investigate the regulation of β1 trafficking by 
Rab11A S177 in arterial myocytes. Cerebral arteries were transfected with empty vectors 
or Rab11A S177A and then cultured for three days. After surface biotinylation, surface 
and intracellular protein under each condition were run on Western blotting and then 
probed with BKα and β1 antibodies. 
 
The data showed that SNP increased surface β1 protein similarly in mock and Rab11A 
S177A groups (Figure 4-10A, B). In the mock group, ET-1 reversed the SNP-induced 
increase in β1 subunit surface protein (Figure 4-10A, B). Rab11A S177A expression 
blocked the ability of ET-1 to inhibit β1 subunit surface expression (Figure 4-10A, B). 
 
 
Rab11A S177A Restores Co-assembly Between BKα and β1 Subunits in the 
Presence of ET-1 
 
Cerebral arteries were transfected with empty vectors (control) or Rab11A S177A 
and then cultured from three days. Then smooth muscle cells were isolated from these 
cerebral arteries. Both group of myocytes were exposed to ET-1 (10 nmol/L, 1h) and then 
SNP (10 µmol/L, 10 min). After treatment, myocytes were fixed and probed with primary 
antibodies and then secondary antibodies. 
 
Confocal imaging of isolated cerebral artery myocytes illustrated that ET-1 
decreased SNP-induced N-FRET signals in myocytes transfected with empty vectors, 
which was similar as fresh isolated myocytes. In contrast, Rab11A S177A expression 





Figure 4-9. Anti-phosphoserine is increased in ET-1-treated cerebral arteries 
expressing Rab11A WT but not Rab11A S177A. 
 
Notes: (A) Representative Western Blots probed with anti-phosphoserine or Rab11A 
antibodies after immunoprecipitation of Rab11A. (B) Mean data of anti-phosphoserine 
band intensity compared to untreated Rab11A WT (n=6). *p <0.05 vs. Rab11A WT 
without ET-1 treatment, # p <0.05 vs. Rab11A WT with ET-1 treatment. (C) ET-1 did 
not change total Rab11A protein in arteries transfected with either Rab11A WT or 
Rab11A S177A. Mean data of total Rab11A protein expression in ET-1-treated cerebral 
arteries transfected with Rab11A WT or Rab11A S177A compared to non-ET-1-treated 






Figure 4-10. ET-1 inhibits β1 subunit surface trafficking through Rab11A serine 
177. 
 
Notes: (A) Representative Western blots illustrating surface (S) and intracellular (I) β1 
and BKα protein in arteries transfected with an empty vector or a vector encoding 
Rab11A S177A in control, SNP (10 µmol/L, 10 min) or SNP (10 µmol/L, 10 min) + ET-
1 (10 nmol/L, 1h), as indicated. (B) Mean data of protein distribution (n=6 for each). 
*p<0.05 vs. control (no agents), # p<0.05 vs. SNP in the mock group, † p<0.05 vs. ET-





secondary antibodies (Figure 4-11C, D). Taken together, these data suggest that ET-1-
induced PKC acts through Ser177 on Rab11A, leading to a reduction in Rab11A activity 
and inhibition of β1 subunit surface trafficking in arterial myocytes. 
 
 
ET-1 Inhibits BK Channels Through PKC-mediated Phosphorylation of Rab11A 
 
  Given that Rab11A S177A expression attenuated ET-1-inhibition of β1 surface 
expression, we measured BK channel regulation by this mutant construct in arterial 
myocytes. Cerebral arteries were transfected with empty vectors (control) or Rab11A 
S177A and then cultured from three days. Then smooth muscle cells were isolated from 
these cerebral arteries. Both group of myocytes were exposed to ET-1 (10 nmol/L, 1h) 
and then SNP (10 µmol/L, 10 min). Cell patches were pulled and then the chamber was 
washed with intracellular solution. The single channel activity of BK channel was 
measured at -40mV and +80mV. 
 
  The mean Po of BK channels in mock-transfected cells treated with ET-1+SNP 
was similar to that non-transfected, fresh-isolated cells in the same experimental 
condition (Figure 4-12A, B). Rab11A S177A expression blocked the ability of ET-1 to 
inhibit BK channels (Figure 4-12A, B). Rab11A S177A did not alter BK channel 
maximal Po (Figure 4-12A, B) or the number of channels in patches (2.2±0.1 and 2.3±0.2 
channels in mock and Rab11A S177A, respectively; p>0.05). These data suggest that ET-
1 inhibits BK channels through Rab11A S177 in arterial myocytes. 
 
 
ET-1 Inhibits Transient BK Currents Through Rab11A S177 
 
In arterial myocytes, BK channels are activated by Ca2+ sparks. (Jaggar, Porter et 
al. 2000) A single Ca2+ spark activates multiple nearby BK channels, leading to a 
transient BK current. To examine the functional relevance of Rab11A S177 on Ca2+ 
spark-induced BK channel activation, transient BK currents were recorded in isolated 
arterial myocytes at a steady holding potential of -40 mV. Mean area under the curve 
(Inoue, Yanagisawa et al.) was calculated for each transient BK current (Figure 4-13A).  
 
SNP similarly increased mean transient BK current AUC in mock-transfected 
cells and in cells expressing Rab11A S177A, by ~2.46- and ~2.42-fold, respectively 
(Figure 4-13C). In mock-transfected cells, ET-1 attenuated the SNP-induced increase in 
mean transient BK current AUC (Figure 4-13A, C). In contrast, Rab11A S177A 
expression inhibited the ability of ET-1 to reduce mean transient BK current AUC 
(Figure 4-13B, C). Rab11A S177A did not alter frequency modulation of transient BK 
currents by SNP or ET-1 (Figure 4-13D). These data suggest that ET-1 reduces transient 
BK current AUC through Rab11A S177. In contrast, Rab11A S177 does not modulate 






Figure 4-11. Rab11A S177A restores co-assembly between BKα and β1 subunits in 
the present of ET-1. 
 
Notes: (A) Representative immunofluorescence and immuno-FRET images for BKα and 
β1 protein in arterial myocytes treated with SNP (10 µmol/L, 10 min) + ET-1 (10 
nmol/L, 1h). Scale bars, 10 μm. (B) Mean N-FRET (%) data between BKα and β1 protein 
of mock group (black bar) and Rab11A S177A group (red bar). (n=10 for each) *p <0.05 







Figure 4-12. ET-1 inhibits BK channels via Rab11A S177. 
 
Notes: (A) Representative BK channel recordings in inside-out patches pulled from 
empty vector-transfected (mock) and Rab11A S177A vector-transfected myocytes after 
exposure to ET-1 (10 nmol/L) + SNP (10 µmol/L) at -40mV and +80mV. (B) Mean BK 
channel Po values obtained from mock-transfected (black bars) and Rab11A S177A 








Figure 4-13. Rab11A S177A attenuates ET-1-inhibition of transient BK currents. 
 
Notes: Representative recordings of transient BK currents measured in arterial myocytes 
transfected with an empty vector (mock, A) or a vector encoding Rab11A S177A (B) 
exposed to SNP (10 µmol/L) and ET-1 (10 nmol/L) at -40mV. The inset (A) indicates 
area under the curve of one transient outward current. (C) Mean data for BK current area 
under the curve (pA·ms, n=6 for each). * p<0.05 vs. control in mock group, # p<0.05 vs. 
SNP in mock group, † p<0.05 vs. ET-1+SNP in mock group. (D) Mean data for transient 




ET-1 Stimulates Vasoconstriction Through Rab11A S177 in Pressurized Arteries 
 
The functional significance of Rab11A-mediated β1 subunit trafficking was 
studied in pressurized, myogenic (60 mmHg) arteries. After the arteries developed tone at 
60 mmHg, arteries were applied to 60K+ PSS to induce vasoconstriction. The 60K+ 
response was then washed away by normal PSS. The arteries were then exposed to 10µM 
or 1µm SNP, which was dissolved in PSS. SNP similarly dilated mock-transfected and 
Rab11A S177A-transfected cerebral arteries (Figure 4-14A, C).  
 
ET-1 applied in the continued presence of SNP stimulated vasoconstriction in 
both mock-transfected and Rab11A S177A-transfected arteries. However, in the presence 
of SNP, ET-1-induced vasoconstriction in Rab11A S177A arteries was ~42.5% less than 
in mock arteries under the same condition (Figure 4-14A, C).  
 
Rab11A S177A expression also reduced vasoconstriction to ET-1 (1-10 nmol/L) 
alone to between 41.2 and 57.5 % of controls (Figure 4-14A, C). In contrast, Rab11A 
S177A did not alter myogenic tone at 60 mmHg or depolarization-induced 
vasoconstriction (60 mmol/L K+) (Figure 4-14D). These data indicate that Rab11A S177 
contributes to ET-1-induced vasoconstriction. 
 
 
Surface Trafficking of β1 Subunit Is Impaired in Myocytes of SP-SHRs Arteries 
 
MAPs were 123±3 and 190±4 mmHg in WKY rats and SP-SHR, respectively 
(p<0.05). Western blotting revealed that BKα and β1 subunit total protein were similar in 
the cerebral arteries of WKYs and SP-SHR (Figure 4-15A, B). Arterial biotinylation 
experiments indicated BKα and β1 proteins were similarly distributed in cerebral arteries 
of WKYs and SP-SHR with >85 % of BKα present in the plasma membrane and >90 % 
of β1 located intracellularly (Figure 4-15A, B). These data indicate that BKα and β1 
subunit total protein and cellular distribution are similar in unstimulated cerebral arteries 
of WKYs and SP-SHR. 
 
We tested the hypothesis that trafficking of BK channel subunits induced by 
vasoactive stimuli is altered in cerebral arteries of SP-SHR during hypertension. 
Responses were measured to SNP, a nitric oxide donor, and membrane depolarization, 
which was produced by increasing extracellular K+ to either 30 or 60 mM (10 min each). 
SNP, 30 mM K+ and 60 mM K+ increased surface β1 protein ~2.2-, 2.3- and 2.5- fold, 
respectively, in WKY arteries (Figure 4-15A, B). In contrast, SNP, 30 mM K+ or 60 mM 
K+ did not alter surface β1 protein levels in SP-SHR arteries (Figure 4-15A, B). SNP, 30 
mM K+ or 60 mM K+ (10 min) did not alter surface levels of BKα in both WKY and SP-
SHR arteries (Figure 4-15A, B). These data indicate that SNP- and depolarization-
induced β1 subunit surface trafficking is functional in WKY rat arteries, but is blocked in 







Figure 4-14. ET-1 stimulates vasoconstriction by inhibiting surface trafficking of 
β1 subunits in pressurized arteries. 
 
Notes: (A) Representative diameter recordings of pressurized mock-transfected and 
Rab11A S177A vector-transfected arteries at 60 mmHg illustrating dilation to SNP (10 
µmol/L) and constriction to ET-1 (10 nmol/L) applied in the presence of SNP. (B) 
Representative diameter traces from arteries at 60 mmHg, illustrating constriction to ET-
1 (10 nmol/L). (C) Mean data illustrating diameter changes in response to: ET-1 (10 
nmol/L) applied in the presence of SNP (10 µmol/L), ET-1 alone (1, 3 and 10 nmol/L) 
and SNP alone (1 and 10 µmol/L) at 60 mmHg. (n=6 for each group) *, #, † and & 
illustrate p<0.05 vs. the mock group in the same condition. (D) Mean data (n=6) of 







Figure 4-15. NO-induced or depolarization-induced β1 subunits trafficking is 
impaired in spontaneous hypertensive rats. 
 
Notes: (A) Representative Western blots showing surface (S) and intracellular (I) β1 
subunits and α subunits. Sodium nitroprusside (SNP, 10 µmol/L) (B) Total BKα and β1 
protein (n=5) compared to WKY control. (C) Surface distribution of β1 subunits and α 





NO-induced Activation of BK Channel Is Reduced in Myocytes of SP-SHR Due to 
Impaired β1 Subunit Trafficking 
 
To investigate the functional consequence of β1 subunit trafficking inhibition, BK 
channel PO was measured in inside-out patches pulled from cerebral artery myocytes. PO 
was measured at -40mV, a physiological membrane potential, or at +80mV to stimulate 
maximal channel activity, using a free intracellular Ca2+ concentration of 10 µM.  
 
At -40 mV, the mean PO of BK channels in patches from control WKY and SP-
SHR myocytes was similar (Figure 4-16A, B). Lithocholate, an activator of β1 subunit-
containing BK channels, was applied directly to inside out-patches. Lithocholate 
increased BK channel PO ~2.4-fold in patches pulled from WKY rat myocytes but did not 
alter PO in patches from SP-SHR myocytes (Figure 4-16A, B). Myocytes were exposed 
to SNP (10 mins) after which the PO of BK channels was measured in inside-out patches 
in the absence of SNP. Myocyte SNP-treatment increased the Po of BK channels ~2.5-
fold in patches from WKYs but did not alter the PO in those from SP-SHRs (Figure 4-
16A, B). Lithocholate increased BK channel PO in SNP-treated WKY rat myocytes such 
that it was ~4.1-fold higher than in the control condition (Figure 4-16A, B).  
 
In contrast, lithocholate did not activate BK channels in SNP-treated SP-SHR 
myocytes (Figure 4-16A, B). These data suggest that in WKY rat myocytes, some β1 
subunits are associated with surface BK channels and that NO stimulates an increase in 
the amount of surface β1 subunits, which increases BK channel PO and activation by a β1 
ligand. In contrast, in SP-SHR myocytes, surface β1 subunits do not appear to be 
associated with BKα and that NO does not stimulate β1 subunit surface trafficking to 
activate BK channels. 
 
 
BIM, a PKC Inhibitor, Enables SNP-induced β1 Subunit Surface Trafficking in SP-
SHR Arteries 
 
We hypothesized that dysfunctional β1 protein in SP-SHR was due to activation 
of PKC pathway. To evaluate the mechanism underlying inhibited β1 subunit trafficking, 
WKY and SP-SHR arteries were exposed to SNP with or without BIM, a PKC inhibitor. 
SNP alone increased surface β1 protein in WKY arteries but did not stimulate β1 protein 
surface trafficking in SP-SHR arteries (Figure 4-17A, B). BIM alone did not alter surface 
β1 protein in both WKY and SP-SHR arteries (Figure 4-17A, B). SNP similarly 
increased surface β1 when applied in either the absence or the presence of BIM (Figure 
4-17A, B).  
 
In contrast, BIM enabled SNP to increase surface β1 subunits ~2.7-fold in SP-
SHR arteries (Figure 4-17A, B). Indeed, in the presence of BIM, SNP-induced surface 
trafficking of β1 subunits was the same as in WKY arteries (Figure 4-17A, B). BKα 
distribution was not altered by SNP or BIM applied either alone or in combination in 






Figure 4-16. NO-induced activation of BK channel is reduced in SP-SHR. 
 
Notes: (A) Representative traces of BK channels exposed to lithocholate (Litho, 150 μM) 
in inside-out patches from SNP (10 μM, 10min)-treated WKY and SP-SHR myocytes. 
SNP, (10 μM), BIM (10 μM, 1h). (B) Mean Po of BK channels under indicated 
conditions (n=6). * p<0.05 vs. control in WKY; # p<0.05 vs. SNP in WKY; δ p<0.05 vs. 






Figure 4-17. NO-induced β1 subunits trafficking is attenuated via PKC activation 
in cerebral arteries of SP-SHR. 
 
Notes: (A) Representative Western blots showing surface (S) and intracellular (I) β1 
subunits and α subunits under indicating conditions: SNP (10 μΜ, 10mins), BIM (10 μM, 
1h), SNP(10 μΜ, 10mins)+BIM(10 μM, 1h). (B) Mean data of surface α and β1 proteins 
from biotinylation experiment (n=5). * p<0.05 vs. control in WKY; # p<0.05 vs. SNP in 




does not alter the trafficking of β1 subunits by NO in WKY rat arteries, but restores NO-
induced β1 subunit trafficking in SP-SHR arteries. 
 
 
Rab11A S177A Restores NO-induced β1 Subunit Surface Trafficking in SP-SHR 
Arteries 
 
ET-1 activates PKC, which phosphorylates Rab11A at S177, leading to inhibition 
of β1 subunit surface trafficking (Zhai, Leo et al. 2017). Given that BIM restored β1 
subunit trafficking in SP-SHR arteries, we evaluated the function of Rab11A S177A. 
Arteries were transfected with an empty vector (mock), or vectors that express either 
wild-type Rab11A (Rab11A WT) or Rab11A S177A, a phosphorylation-deficient 
Rab11A mutant. Vectors encoding Rab11A WT or Rab11A S177A similarly increased 
Rab11A total protein to ~162.6% or ~160.3% of the mock group (Figure 4-18A, B).  
 
SNP similarly stimulated a ~3-fold increase in surface β1 subunits in WKY 
arteries overexpressing either Rab11A WT or Rab11A S177A (Figure 4-18C, D). SNP-
induced surface trafficking of β1 subunits was impaired in SP-SHR cerebral arteries 
transfected with Rab11A WT (Figure 4-18C, D). In contrast, Rab11A S177A restored 
SNP-induced β1 surface trafficking in SP-SHR arteries (Figure 4-18C, D). These data 
suggest that PKC-mediated phosphorylation of Rab11A S177 inhibits β1 surface 
trafficking in cerebral arteries of SP-SHR. 
 
 
Rab11A S177A Restores BK Channel Activation in SP-SHR Arterial Myocytes 
 
To examine the modulation of BK channel PO by Rab11A S177, myocytes were 
isolated from WKY or SP-SHR arteries overexpressing Rab11A or Rab11A S177A. 
Myocytes were exposed to SNP (10 mins), after which inside-out patches were pulled 
and BK channels recorded in the absence of SNP. BK channel PO was similar in WKY rat 
myocytes expressing either Rab11A or Rab11A S177A (Figure 4-19A, B).  
 
In patches from SP-SHR arteries expressing Rab11A WT, mean BK channel PO 
was ~60% of that in WKY myocytes expressing the same construct (Figure 4-19A, B). 
The expression of Rab11A S177A increased BK channel PO in SP-SHR myocytes, such 
that it was the same as in WKY myocytes under the same condition (Figure 4-19A, B).  
 
The application of lithocholate to inside-out patches similarly increased BK 
channel PO ~1.8-fold in WKY rat myocytes expressing either Rab11A WT or Rab11A 
S177A (Figure 4-19A, B). Lithocholate did not increase BK channel PO in SP-SHR 
myocytes expressing Rab11A WT (Figure 4-19A, B).  
 
In contrast, Rab11A S177A expression restored lithocholate-induced activation of 
BK channels in SNP-treated SP-SHR myocytes, such that PO was the same as in WKY 






Figure 4-18. Rab11A S177A restores SNP-induced surface-trafficking of β1 
subunits in cerebral arteries of SP-SHRs. 
 
Notes: (A) Representative western blots of Rab11A, BKα, β1 subunits and actin. (B) 
Mean data of Rab11A protein compared with control (n=5). * p<0.05 vs. mock. (C) 
Representative Western blots showing surface (S) and intracellular (I) β1 subunits and α 
subunits after transfection under each indicating condition. (D) Mean data of surface 
protein of β1 subunits and α subunits. (n=5) * p<0.05 vs. control (no SNP) in WKY; # 







Figure 4-19. Rab11A S177A increases mean Po via stimulating β1 subunits 
trafficking in SP-SHR. 
 
Notes: (A) Representative traces recording BK channels from smooth muscle cells 
transfected with Rab11A WT or Rab11A S177A under indicating conditions. (B) Mean 
Po of inside-out patches after transfection (n=6). * p<0.05 vs. SNP in WKY Rab11A 
WT; & p<0.05 vs. SNP+litho in WKY Rab11A WT; # p<0.05 vs. SNP in SP-SHR 




Rab11A S177A expression restores SNP-induced BK channel activation, supporting 
other evidence here that PKC-mediated phosphorylation of Rab11A S177 blocks BK 
channels in SP-SHR myocytes. 
 
 
Impaired β1 Subunit Trafficking Attenuates BK Channel Functionality in 
Pressurized SP-SHR Arteries 
 
The functional impact of dysfunctional β1 trafficking was investigated by 
measuring the contractility of pressurized cerebral arteries. At an intravascular pressure 
of 60 mmHg, endothelium-denuded SP-SHR arteries developed 36.1±1.8 % tone 
compared with 23.9 ±4.0 % tone in WKY arteries, or ~1.5-fold more (n=, 6; P<0.05).  
 
SNP and lithocholate increased the mean diameter of SP-SHR arteries by ~4 and 
6 μm, respectively, responses that were ~26 and 48 %% of those in WKY rat arteries 
(Figure 4-20A, B). SNP increased lithocholate-induced dilation from~ 6 to 20 µm in 
WKY rat arteries and from ~3 to 7 µm in SP-SHR arteries. Thus, lithocholate-induced 
vasodilation in the presence of SNP was ~2.8-fold more in WKY than SP-SHR arteries 
(Figure 4-20B). BIM increased SNP-induced vasodilation in SP-SHR arteries to the 
same as in WKY rat arteries (Figure 4-20B).  
 
BIM also increased lithocholate-induced vasodilation obtained in the presence of 
SNP in SP-SHR arteries to the same as that in WKY rat arteries (Figure 4-20B). In 
contrast, BIM alone did not alter WKY rat or SP-SHR artery diameter (Figure 4-20B). 
BIM also did not alter vasodilation to SNP or lithocholate in WKY rat arteries (Figure  
4-20B) These data support our biochemical evidence that dysfunctional mobilization of 
myocyte BK channel β1 subunits greatly attenuates BK channel functionality through 







Figure 4-20. Activation of PKC dampens NO-mediated vasodilation in SP-SHR. 
 
Notes: (A) Representative traces of changes in arterial diameter from WKY rats (blue) 
and SP-SHR (red). (B) Mean data illustrating diameter changes (n=6 for each). * p<0.05 
vs. control in WKY; # p<0.05 vs. WKY in the same condition; δ p<0.05 vs. SNP in SP-








CHAPTER 5.    DISCUSSION* 
 
 
Summary of Findings 
 
Here, the aim of this study was to investigate the mechanism how β1 subunits 
trafficking regulated by vasoconstrictors. Our data indicate that endothelin-1 inhibited β1 
subunits anterograde trafficking to the cell surface via activation of PKC. The inhibitory 
effect of β1 subunits anterograde trafficking by ET-1 reduces the open probability of BK 
channel. It has been shown that β1 subunits are co-localized with Rab11A positive 
recycling endosome. SNP increases active Rab11 whereas ET-1 reduces active Rab11. 
Active Rab11A facilitates β1 subunits trafficking towards the cell surface. Activation of 
PKC phosphorylates Rab11A, particularly S177, to inhibit the activity of Rab11A. Loss 
activity of Rab11A fails to stimulate β1 subunits trafficking to the cell surface. Rab11A 
S177A reduces the open probability and the transient outward currents of BK channels. 
Moreover, Rab11A S177A attenuates ET-1 induced vasoconstriction. Thus, we conclude 
that ET-1 inhibits β1 subunits anterograde trafficking by phosphorylating Rab11A on 
S177 via activation of PKC. 
 
We also tested the hypothesis that hypertension is associated with altered 
trafficking of BK channel subunits in myocytes of cerebral arteries using SP-SHRs as a 
disease model and WKY rats as a control. Our data show that stimulated surface 
trafficking of β1 subunits by NO or membrane depolarization is inhibited in arterial 
myocytes of SP-SHRs. PKC inhibition or expression of Rab11AS177A, a PKC 
phosphorylation-deficient mutant, restores β1 subunit surface-trafficking in SP-SHR 
arteries. BK channel activation by NO is attenuated due to the impaired trafficking of β1 
subunits in arterial myocytes of SP-SHRs. BK channel activation by NO is restored by 
Rab11AS177A in SP-SHR myocytes. PKC inhibition also enables NO-induced 
vasodilation by reestablishing the ability of NO to increase the abundance of β1 subunits 
associated with surface BKα. These data demonstrate that spontaneously active PKC 
blocks the ability of NO to stimulate β1 subunit surface trafficking in myocytes of SP-




ET-1 Inhibits NO or Depolarization-induced Surface Trafficking of β1 Subunits in 
Myocytes of SD Rats 
 
Previous studies have shown that SNP and membrane depolarization, stimulate 
anterograde trafficking of recycling endosomes via PKG or ROCK pathway, respectively.  
 
--------------- 
* Portions of this chapter adapted with permission. Zhai, X., M. D. Leo and J. H. Jaggar 
(2017). "Endothelin-1 Stimulates Vasoconstriction Through Rab11A Serine 177 
Phosphorylation." Circ Res 121(6): 650-661.  
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β1 subunits was delivered to the cell surface in arterial myocytes. (Leo, Bannister et al. 
2014, Leo, Zhai et al. 2017) β1 subunits has been shown to increase apparent 
Ca2+sensitivity of BK channels when β1 subunits are associated with pore forming α 
subunits. β1 subunits are dynamically trafficked back and force from the cell surface to 
intracellular endosome. SNP, the vasodilator, is stimulated the anterograde trafficking of 
β1 subunits to cell surface. This led us to propose that the vasoconstrictors act the 
opposite way against vasodilators. Because only ~8% of β1 subunits are presented at cell 
surface at physiological level, ET-1 did not significantly reduce the surface expression. 
However, the functional studies from myography did show the ~20% attenuation of ET-1 
vasoconstriction. Although ET-1 does not significantly reduce surface expression of β1 
subunits, ET-1 retains β1 subunits in the intracellular compartment resulting in 
vasoconstriction. But ET-1 significantly reduced NO-induce β1 subunits anterograde 
trafficking. BIM-1, the PKC inhibitor, ablated the inhibitory effect of ET-1 on β1 
subunits anterograde trafficking.  
 
Studies has shown that PKG and PKC regulates the open probability of BK 
channels. Activation of PKG by vasodilators increases the open probability of BK 
channels by stimulating β1 subunits trafficking to the cell surface. Activation of PKC by 
long period of time decrease BK channel currents due to internalization and degradation 
of BKα channels. Our data indicate that that activation of PKC also reduces the open 
probability of BK channel by blocking β1 subunits trafficking to the cell surface. 
 
 
Rab11A Protein Functions in β1 Subunits Trafficking 
 
Rab protein belongs to small GTPases that control protein trafficking in various 
types of cells. (Zerial and McBride 2001, Stenmark 2009) β1 subunits have been shown 
to be co-localized with Rab11A in recycling endosome in smooth muscle cells.(Leo, 
Bannister et al. 2014) β1 subunits was not stimulated by SNP in Rab11A knockdown 
smooth muscle cells. (Leo, Bannister et al. 2014) It still remains unknown that how 
activation of PKG stimulates protein trafficking of β1 subunits. It is possible that PKG 
directly phosphorylate Rab11A which then activate Rab11A. Another possibility could 
be PKG activate other signaling protein which then activates Rab11A indirectly. We 
could not exclude that PKG does not alter Rab11A activity. Here, our data show that 
Rab11 activity is increased by NO in arterial myocytes. It indicates that PKG activates 
Rab11A. We also show that ET-1 reduces Rab11A activity, demonstrating that 
differential regulation of Rab11A activity controls surface β1 trafficking. On the other 
hand, PKC may control upstream proteins or directly phosphorylate Rab11A so that it 
inhibits Rab11A activity. To test these possibilities, bioinformatics showed that five 
possible sites in Rab11A might be phosphorylated by PKC, whereas S177 has the highest 
possibility. To test S177 function, we transfected cerebral arteries with Rab11A S177A. 
Rab11A S177A reduced ET-stimulated phosphorylation of Rab11A in cerebral arteries. 
The data indicate that Rab11A S177 is phosphorylated by protein kinase C which results 
in a decrease in activity of Rab11A. ET-1-reduced surface trafficking of β1 protein was 
also attenuated by Rab11A S177A. On the other hand, NO-induced surface trafficking of 
β1protein was not changed by Rab11A S177A. The explanation might be that Rab11A is 
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activated by NO via a different pathway that is not involved in S177. Previous finding 
suggested that a PKC activator (phorbol myristate acetate) activated Rab11 
phosphorylation in HeLa cells expressing Rab11.(Pavarotti, Capmany et al. 2012) 
Moreover, serotonin (5-HT) activated PKC which induced sequestration of 5-HT 
receptors into a Rab11-positive endosome in HEK293 cells.(Idkowiak-Baldys, Baldys et 
al. 2009) In summary, our data indicate that ET-1 stimulates PKC-mediated 
phosphorylation of Rab11A serine 177, leading to a decrease in Rab11A activity and a 
reduction in surface β1 subunits in arterial myocytes. 
 
 
PKC Pathway Is Involved in β1 Subunits Trafficking 
 
Vasoregulatory stimuli regulate activity of BK channel through protein kinases in 
arterial myocytes.(Barman 1999, Schubert, Noack et al. 1999, Betts and Kozlowski 2000, 
Taguchi, Kaneko et al. 2000, Barman, Zhu et al. 2004, McNair, Salamanca et al. 2004, 
Rainbow, Norman et al. 2009) Previous studies showed that the whole-cell BK currents 
was inhibited by ET-1 in rat renal artery myocytes, but the mechanisms involved were 
not fully understood.(Betts and Kozlowski 2000) The inside-out membrane patche data 
showed that the activity of BK channels was increased by PKA and PKG in arterial 
myocytes.(Robertson, Schubert et al. 1993, White, Kryman et al. 2000, Schubert and 
Nelson 2001) In contrast, BK channels was inhibits by PKC in inside-out 
patches.(Bonev, Jaggar et al. 1997, Zhou, Wulfsen et al. 2010) The frequency of Ca2+ 
sparks was also modulated by PKA, PKG, and PKC to control BK channel activity 
indirectly. (Jaggar, Porter et al. 2000) Here, we showed that a vasoconstrictor (ET-1) 
decreased anterograde trafficking of β1 subunits and surface expression of β1 proteins to 
inhibit BK channels. Previous data similarly suggested that an increase of mean Po in BK 
channel was caused by an increase in surface β1 protein by NO stimulation. (Leo, 
Bannister et al. 2014) In contrast, mean Po of BK channel was inhibited by ET-1-induced 
PKC activation in membrane patches. We showed that ET-1-inhibition of BK channel 
activity was reversed by BIM and Rab11A S177A. It supported the biochemistry data 
that PKC-induced phosphorylation of Rab11A S177 inhibited β1 anterograde trafficking 
in smooth muscle cells.  
 
 
Rab11A S177A Enables Transient Outward Currents in Presence of ET-1 
 
Ca2+ sparks are generated by sarcoplasmic reticulum which activate several 
nearby BK channels in arterial myocytes.(Jaggar, Porter et al. 2000) To study how Ca2+ 
sparks was modulated by Rab11A S177, we measured transient BK currents by whole 
cell configuration in smooth muscle cells. Previous study showed similar data that SNP 
increased both mean AUC and frequency of transient BK current. (Porter, Bonev et al. 
1998) Here, we showed that Rab11A S177A did not alter the SNP-induced increase in 
transient BK current frequency or AUC. It indicated that PKG activates transient BK 
current via S177-independent mechanism. ET-1 inhibited an increase in transient BK 
current frequency and mean AUC induced by NO in control myocytes. However, the ET-
1-induced reduction in mean AUC was reversed by Rab11A S177A in transfected 
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arteries. It suggested that the effective coupling of BK channels to Ca2+ sparks was 
attenuated by ET-1 mediated activation of PKC. Furthermore, S177A did not alter the 
ET-1 mediated decrease in transient BK current frequency. Ca2+ spark frequency 
determines transient BK current frequency because Ca2+ sparks activate a transient BK 
current in rat cerebral artery myocytes. (Jaggar, Porter et al. 2000) It indicated that 
Rab11A S177 did not modify Ca2+ spark frequency so that it did not change frequency of 
transient outward currents. Our data indicate that ET-1 phosphorylates Rab11A at S177 
in order to inhibit BK channel transient BK currents. 
 
 
Rab11A S177A Attenuates ET-1-induced Vasoconstriction 
 
ET-1 activates protein kinase C which phosphorylates myosin light chain to 
induce vasoconstriction. (Kamm and Stull 1985, Adam, Milio et al. 1990, Somlyo and 
Somlyo 2003, Davenport, Hyndman et al. 2016) Here, our data indicated that ET-1-
induced vasoconstriction was impaired by Rab11A S177 in the presence of SNP. 
Moreover, vasoconstriction to various concentration of ET-1 was also reduced by 
Rab11A S177A overexpression in cerebral arteries. These data also were consistent with 
the data that membrane depolarization induced by intravascular pressure was attenuated 
by ET-1 by inhibiting β1 surface trafficking. (Leo, Zhai et al. 2017) In contrast, 
membrane depolarization (60 mmol/L K+)-induced vasoconstriction was not altered by 
Rab11A S177A because 60 K+ induced very potent vasoconstriction which might mask 
the effect of Rab11A S177A. Myogenic tone was not changed by Rab11A S177A either. 
It suggested that Rab11A S177A is not a non-specific inhibitor of vasoconstriction. In 
summary, our data demonstrate that ET-1 induces vasoconstriction by blocking β1 
subunit surface trafficking and in turn inhibiting BK channel activity. 
 
 
Surface Trafficking of β1 Total Proteins in SP-SHR Arteries 
 
Cerebral arteries from hypertensive subjects are depolarized and 
constricted.(Harder, Brann et al. 1983, Harder, Smeda et al. 1985) Endothelium-
dependent vasodilation, including that produced by NO, is attenuated in vessels from 
multiple hypertensive animal models.(Luscher, Aarhus et al. 1990, Cordellini 1999, 
Heitzer, Wenzel et al. 1999, Zhou, Kosaka et al. 2001, Yang, Gluais et al. 2004, 
Quaschning, Hocher et al. 2006, Jimenez, Lopez-Sepulveda et al. 2007, Choi, Allahdadi 
et al. 2011)  
 
Given that BK channels regulate physiological arterial potential and contractility, 
we investigated whether pathological changes in BK channel trafficking alter arterial 
function during hypertension. We used SP-SHR, a rat genetic model of hypertension that 
is prone to stroke, to study the cellular distribution and regulation of BKα and β1 subunit 
total and surface abundance. Our data show that BKα and β1 total and surface proteins 
are similar in cerebral arteries of age-matched hypertensive SP-SHRs and normotensive 
WKY rat controls. Our data are in agreement with the findings of some, but not all, 




Consistent with our results, Pabbidi reported that BKα and β1 total proteins were 
similar in cerebral arteries of a hypertensive model of Fawn Hooded rats, when compared 
with their normotensive genetic controls (Pabbidi, Mazur et al. 2014). Other studies have 
reported that BKα mRNA is unaltered, but β1 mRNA was lower in cerebral arteries of 
angiotensin II-infused hypertensive Sprague-Dawley rats and mice and SHRs, when 
compared with their respective controls (Amberg, Bonev et al. 2003, Amberg and 
Santana 2003). Another study found that although BKα mRNA was similar, BKα protein 
was higher in cerebral arteries of SHR and WKYs (Liu, Hudetz et al. 1998). Some of 
these different findings may relate to the approaches used to measure BK channel subunit 
expression or the animal models of hypertension that were examined. Regardless, our 
data show that the altered functionality of BK channels described here in SP-SHR 
cerebral arteries is not due to a change in BKα or β1 total proteins. 
 
 
Rab11A-mediated Β1 Subunits Trafficking in Myocytes of SP-SHRs 
 
We previously described that in unstimulated arteries, low levels of β1 subunits 
are trafficked to the surface via a Rab11A-independent mechanism (Leo, Bannister et al. 
2014). Our data here suggest that the surface-trafficking of these basal β1 subunits is not 
altered in SP-SHR. NO and membrane depolarization stimulate Rab11A-dependent 
trafficking of β1 subunits to the plasma membrane in arterial myocytes, but through 
distinct signaling mechanisms: NO operates through PKG activation, whereas 
depolarization acts via the stimulation of ROCK (Leo, Bannister et al. 2014, Leo, Zhai et 
al. 2017).  Regardless of the signaling mechanisms involved, surface-trafficked β1 
proteins associate with plasma membrane-resident BKα, leading to channel activation 
(Leo, Bannister et al. 2014, Leo, Zhai et al. 2017).  
 
Here, NO and membrane depolarization failed to surface-traffic β1 subunits in 
cerebral arteries of SP-SHRs, indicating the presence of an endogenous inhibitory 
mechanism. We recently described that endothelin-1 activates protein kinase C, which 
phosphorylates Rab11A at Serine 177. (Zhai, Leo et al. 2017)  This mechanism reduces 
Rab11A activity and blocks β1 subunit surface trafficking in arterial myocytes (Zhai, Leo 
et al. 2017). Given that NO stimulates Rab11A, it leads us to hypothesize that activated 
PKC activation may prevent β1 trafficking in myocytes of SP-SHR (Zhai, Leo et al. 
2017).  
 
Data we provide here support this mechanism, including that BIM and 
Rab11AS177A, a mutant Rab11A that is unable to be phosphorylated by PKC at serine 
177, enabled NO-induced trafficking of β1 subunits in SP-SHR arteries. In contrast, the 
overexpression of Rab11A did not reestablish β1 trafficking, indicating that the inhibitory 
mechanism was not specific to endogenous Rab11A and could not be overcome by 
increasing the amount of Rab11A. Identifying the mechanism by which PKC is 
spontaneously activated in arteries of SP-SHRs was not a focus of our study, but several 
possibilities exist. An increase in the expression, translocation and activity of PKC has 
been implicated in the pathogenesis of hypertension and one or more of these signaling 
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alterations may underlie PKC-mediated Rab11A inhibition in SP-SHR arterial myocytes 
(Salamanca and Khalil 2005).  
 
Our data show that PKC is active in unstimulated arteries in vitro. The PKC-
mediated inhibitory mechanism was also present in arteries that had been placed in 
serum-free media for 2 days. These data suggest that the mechanism of PKC activation 
occurs in the isolated arterial wall and that in vivo factors, such as circulating 
vasoconstrictors, are not required for this PKC activity and inhibition of β1 trafficking in 
arterial myocytes of SP-SHRs.  
 
PKC can be activated by many different intracellular signal elements, including 
diacyglycerol, Ca2+ and reactive oxygen species. Studies have shown that intracellular 
Ca2+ concentration and Ca2+ sparklet activity are increased in arterial myocytes during 
hypertension (Nieves-Cintron, Amberg et al. 2007, Joseph, Thakali et al. 2013). 
Hypertension is also associated with an increase in the bioavailability of vascular reactive 
oxygen species (Montezano, Dulak-Lis et al. 2015). One or more of these multiple 
mechanisms may activate PKC, leading to the inhibition of β1 trafficking in arterial 
myocytes of SP-SHRs. 
 
 
Regulation of BK Channel Activity by β1 Subunits Trafficking in Myocytes of SP-
SHRs  
 
BK channels formed from four α subunits can contain between one and four β1 
subunits (Knaus, Garcia-Calvo et al. 1994, Wang, Ding et al. 2002).  The α:β1-tetramer 
ratio shifts channel voltage- and Ca2+ dependence, with an increase in the number of β1 
subunits elevating channel activity(Wang, Ding et al. 2002). Here, we applied 
lithocholate directly to inside-out patches to evaluate the presence of channels containing 
β1 subunits. Although surface β1 protein was similar in unstimulated WKY and SP-SHR 
myocytes, lithocholate activated BK channels only in patches from WKY rats and not in 
patches from SP-SHRs. Thus, plasma membrane β1 subunits in unstimulated SP-SHR 
arterial myocytes do not activate BK channels.  Explanations for this finding include that 
a pathological signaling mechanism prevents low levels of β1 subunits from either 
activating or physically associating with BKα in in SP-SHR myocytes. 
 
SNP increased both BK channel PO and lithocholate-induced channel activation in 
excised patches from WKY rat myocytes, indicating that NO increased the abundance of 
β1 subunits associated with BKα. In contrast, SNP did not activate BK channels or enable 
lithocholate-induced BK channel activation in SP-SHR myocytes, consistent with other 
data here that NO did not traffic β1 subunits to the surface in these cells.  The 
overexpression of Rab11A did not enable NO- or lithocholate-activation of BK channels 
in SP-SHR arterial myocytes. In contrast, Rab11A S177A reestablished both NO- and 
lithocholate-activation of BK channels. These data suggest that PKC acting through 
Rab11A S177 inhibits β1 subunit surface-trafficking, thereby preventing NO from 





Spontaneous Activated PKC Inhibits Vasodilation of SP-SHR Arteries 
 
Functional data also support the signaling mechanism identified here using 
biochemistry and electrophysiology. In pressurized WKY rat arteries, SNP and 
lithocholate both stimulated dilation, SNP increased lithocholate-induced vasodilation 
and BIM did not alter these responses.  In contrast, in SP-SHR arteries, SNP and 
lithocholate-induced dilations were small, SNP did not increase lithocholate-induced 
dilation, BIM increased SNP-induced vasodilation and enabled SNP to augment dilation 
to lithocholate. Importantly, BIM increased SNP-induced vasodilation such that it was 
the same as in WKY rat arteries. These data indicate that PKC-mediated inhibition of β1 
subunit trafficking underlies dysfunctional NO-induced vasodilation in SP-SHR cerebral 
arteries.  
 
As discussed above, studies have reported either no change or alterations in the 
abundance of BK channel subunits in hypertensive animal models. The upregulation of 
BK currents in arterial myocytes during SHRs is reported to elicit compensatory 
vasodilation (Liu, Hudetz et al. 1998).  In contrast, a reduction in β1 subunits has been 
described to decrease BK channel activity, producing vasoconstriction in angiotensin II-
infused hypertensive Sprague-Dawley rats and mice and SHRs (Amberg, Bonev et al. 
2003, Amberg and Santana 2003, Nieves-Cintron, Amberg et al. 2007). Our data indicate 
that BKα and β1 total protein is unaltered and myogenic tone is higher in pressurized 
arteries of SP-SHRs than WKY rats.  It was not a focus of this study to investigate the 
underlying mechanisms for increased myogenic tone and whether BK channels contribute 
to this vasoconstriction or oppose it. BIM alone did not alter the diameter of either WKY 
rat or SP-SHR arteries, suggesting that the net effect of PKC activation does not 
contribute to the increase in myogenic tone.  Other mechanisms, including those 
mediated through voltage-dependent K+ (KV) and CaV1.2 channels contribute to this 
pathological vasoconstriction (Joseph, Thakali et al. 2013). Our data show that NO-
induced vasodilation is attenuated due to PKC-mediated inhibition of β1 subunit 





In summary, we show that ET-1 activates PKC, which phosphorylates Rab11A 
S177, leading to a decrease in Rab11A activity and a reduction in β1 subunit surface 
trafficking. The ET-1-induced reduction in β1 subunit surface delivery inhibits BK 
channels and transient BK currents, leading to vasoconstriction. In contrast, NO activates 
Rab11A and increases surface β1 subunits through a Rab11A S177-independent 
mechanism. In summary, we show that differential regulation of Rab11A by ET-1 and 
NO controls BK channels and contractility in arterial myocytes. (Figure 5-1) 
 
We also show that that activated PKC blocks the stimulated surface trafficking of 






Figure 5-1. Signaling pathways of the β1 subunit trafficking in arterial myocytes. 
 
Notes: Nitric oxide (NO) stimulates surface trafficking of β1 subunits via PKG 
activation. Endothelin-1 (ET-1) activates PKC to phosphorylate Ser177 on Rab11A, 
which inhibits NO-induced surface trafficking of β1 subunits towards cell surface. It 
reduces BK channel activity which in turn decreases inhibition of Cav1.2 channel and 




Inhibition of this PKC-mediated inhibitory mechanism restores both stimulated surface 
trafficking of β1 subunits, BK channel activation and vasodilation. (Figure 5-2) 
 
 
Novelty and Significance 
 
Large-conductance calcium (Ca2+)-activated potassium channels (BK) are 
expressed in arterial smooth muscle cells and regulate contractility. β1 subunit 
anterograde trafficking is controlled by Rab11A, a Rab GTPase, and surface abundance 
can be increased by several stimuli that activate BK channels, including nitric oxide and 
membrane depolarization, leading to vasodilation. Whether vasoconstrictors modulate the 
surface trafficking of β1 subunits to inhibit BK channels is unclear. 
 
We show that endothelin-1, a potent vasoconstrictor, stimulates protein kinase C, 
which phosphorylates Rab11A at serine 177, reducing Rab11A activity and Rab11A-
dependent surface trafficking of β1 subunits. The endothelin-1-induced decrease in 
surface β1 subunits inhibits BK channels, resulting in vasoconstriction. 
 
Arterial contractility is modulated by both vasoconstrictor and vasodilator stimuli, 
leading to changes in regional organ blood flow and systemic blood pressure. Several 
different ion channels are expressed in arterial smooth muscle cells, but whether 
regulated trafficking of these proteins controls contractility is poorly understood. In 
arterial myocytes, BK channel consists of BKα subunits and β1 subunits. Recent 
evidence indicates that BKα is primarily located in the plasma membrane, whereas β1 
subunits are dynamic proteins whose localization can be modulated. It is unclear whether 
vasoconstrictors inhibit BK channels and stimulate contraction by reducing the surface 
abundance of β1 subunits and their association with surface BKα. We show that ET-1 
stimulates protein kinase C-mediated phosphorylation of Rab11A, a Rab GTPase, at 
serine 177, which inhibits Rab11A and Rab11A-mediated surface trafficking of β1 
subunits. This mechanism inhibits BK channels, leading to vasoconstriction. Our study 
describes a unique mechanism by which a vasoconstrictor inhibits BK channels to 
stimulate contraction and identify Rab11A serine 177 as a potential target site by which 
to modulate arterial contractility. 
 
Findings of our study may be relevant for human cardiovascular diseases. Single 
nucleotide polymorphisms (SNPs) in BKα and β1 genes contribute to human 
cardiovascular diseases, including hypertension (Kohler 2010). More than 140 SNPs have 
been reported in or nearby the β1 subunit gene. An E65K polymorphism in β1 produces a 
"gain-of-function" mutant which increases BK channel Ca2+-sensitivity and is associated 
with lower prevalence for diastolic hypertension (Fernandez-Fernandez, Tomas et al. 
2004). BK channel Ca2+-sensitivity is lower in β1 subunit knockout mice, which leads to 
membrane depolarization, vasoconstriction and systemic hypertension (Brenner, Perez et 
al. 2000). These studies provide a link between altered β1 subunit function, vascular 
reactivity and blood pressure. Whether SNPs in β1 subunits interfere with protein surface 






Figure 5-2. Schematic figure shows the β1 subunit trafficking in arterial myocytes 
of SP-SHRs. 
 
Notes: Spontaneous active PKC blocks the stimulated surface trafficking of β1 subunits 





The stimulated surface-trafficking of BK channel β1 subunits by either nitric 
oxide or membrane depolarization is inhibited in cerebral artery smooth muscle cells of 
stroke-prone spontaneously hypertensive rats (SP-SHR). Spontaneously active protein 
kinase C inhibits β1 subunit trafficking, which attenuates BK channel activation in 
arterial smooth muscle cells of SP-SHRs. PKC inhibition or overexpression of a 
phosphorylation-incapable Rab11A mutant (Rab11AS177A) restores stimulated β1 
subunit trafficking and BK channel activation. PKC inhibition restores vasodilation to 
NO by enabling β1 subunit trafficking in cerebral arteries of SP-SHRs. 
 
Hypertension is associated with vasoconstriction, attenuated NO-mediated 
vasodilation, and alterations in BK channel functionality, although interplay between 
these pathological modifications and mechanisms involved are unclear. The regulated 
surface-trafficking of BK channel α and β1 subunits in smooth muscle cells is a 
mechanism recently described to control arterial contractility. Whether BK channel 
subunit trafficking is altered during cardiovascular diseases and leads to changes in 
functionality is unclear. 
 
Our data indicate that spontaneously active PKC inhibits β1 subunit trafficking in 
smooth muscle cells and is responsible for dysfunctional NO-induced BK channel 






LIST OF REFERENCES 
 
 
Adam, L. P., L. Milio, B. Brengle and D. R. Hathaway (1990). "Myosin light chain and 
caldesmon phosphorylation in arterial muscle stimulated with endothelin-1." J Mol Cell 
Cardiol 22(9): 1017-1023. 
 
Amberg, G. C., A. D. Bonev, C. F. Rossow, M. T. Nelson and L. F. Santana (2003). 
"Modulation of the molecular composition of large conductance, Ca2+ activated K+ 
channels in vascular smooth muscle during hypertension." J Clin Invest 112(5): 717-724. 
 
Amberg, G. C. and L. F. Santana (2003). "Downregulation of the BK channel beta1 
subunit in genetic hypertension." Circ Res 93(10): 965-971. 
 
Archer, S. L., J. M. Huang, V. Hampl, D. P. Nelson, P. J. Shultz and E. K. Weir (1994). 
"Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive 
K channel by cGMP-dependent protein kinase." Proc Natl Acad Sci U S A 91(16): 7583-
7587. 
 
Bannister, J. P., A. Adebiyi, G. Zhao, D. Narayanan, C. M. Thomas, J. Y. Feng and J. H. 
Jaggar (2009). "Smooth muscle cell α2δ-1 subunits are essential for vasoregulation by 
CaV1.2 channels." Circ Res 105(10): 948-955. 
 
Bannister, J. P., S. Bulley, M. D. Leo, M. W. Kidd and J. H. Jaggar (2016). "Rab25 
influences functional Cav1.2 channel surface expression in arterial smooth muscle cells." 
Am J Physiol Cell Physiol 310(11): C885-893. 
 
Barman, S. A. (1999). "Potassium channels modulate canine pulmonary vasoreactivity to 
protein kinase C activation." Am J Physiol 277(3 Pt 1): L558-565. 
 
Barman, S. A., S. Zhu and R. E. White (2004). "Protein kinase C inhibits BKCa channel 
activity in pulmonary arterial smooth muscle." Am J Physiol Lung Cell Mol Physiol 
286(1): L149-155. 
 
Berridge, M. J. (1984). "Inositol trisphosphate and diacylglycerol as second messengers." 
Biochem J 220(2): 345-360. 
 
Betts, L. C. and R. Z. Kozlowski (2000). "Electrophysiological effects of endothelin-1 
and their relationship to contraction in rat renal arterial smooth muscle." Br J Pharmacol 
130(4): 787-796. 
 
Bonev, A. D., J. H. Jaggar, M. Rubart and M. T. Nelson (1997). "Activators of protein 
kinase C decrease Ca2+ spark frequency in smooth muscle cells from cerebral arteries." 




Bonev, A. D. and M. T. Nelson (1993). "Muscarinic inhibition of ATP-sensitive K+ 
channels by protein kinase C in urinary bladder smooth muscle." Am J Physiol 265(6 Pt 
1): C1723-1728. 
 
Brenner, R., G. J. Perez, A. D. Bonev, D. M. Eckman, J. C. Kosek, S. W. Wiler, A. J. 
Patterson, M. T. Nelson and R. W. Aldrich (2000). "Vasoregulation by the beta1 subunit 
of the calcium-activated potassium channel." Nature 407(6806): 870-876. 
 
Brozovich, F. V., C. J. Nicholson, C. V. Degen, Y. Z. Gao, M. Aggarwal and K. G. 
Morgan (2016). "Mechanisms of Vascular Smooth Muscle Contraction and the Basis for 
Pharmacologic Treatment of Smooth Muscle Disorders." Pharmacol Rev 68(2): 476-532. 
 
Bryan, J. (1990). "Caldesmon: fragments, sequence, and domain mapping." Ann N Y 
Acad Sci 599: 100-110. 
 
Chabrashvili, T., A. Tojo, M. L. Onozato, C. Kitiyakara, M. T. Quinn, T. Fujita, W. J. 
Welch and C. S. Wilcox (2002). "Expression and cellular localization of classic NADPH 
oxidase subunits in the spontaneously hypertensive rat kidney." Hypertension 39(2): 269-
274. 
 
Chen, W., Y. Feng, D. Chen and A. Wandinger-Ness (1998). "Rab11 is required for 
trans-golgi network-to-plasma membrane transport and a preferential target for GDP 
dissociation inhibitor." Mol Biol Cell 9(11): 3241-3257. 
 
Choi, H., K. J. Allahdadi, R. C. Tostes and R. C. Webb (2011). "Augmented S-
nitrosylation contributes to impaired relaxation in angiotensin II hypertensive mouse 
aorta: role of thioredoxin reductase." J Hypertens 29(12): 2359-2368. 
 
Christoforidis, S., H. M. McBride, R. D. Burgoyne and M. Zerial (1999). "The Rab5 
effector EEA1 is a core component of endosome docking." Nature 397(6720): 621-625. 
 
Contreras, G. F., A. Neely, O. Alvarez, C. Gonzalez and R. Latorre (2012). "Modulation 
of BK channel voltage gating by different auxiliary β subunits." Proc Natl Acad Sci U S 
A 109(46): 18991-18996. 
 
Cordellini, S. (1999). "Endothelial dysfunction in DOCA-salt hypertension: possible 
involvement of prostaglandin endoperoxides." Gen Pharmacol 32(3): 315-320. 
 
D'Souza, R. S., R. Semus, E. A. Billings, C. B. Meyer, K. Conger and J. E. Casanova 
(2014). "Rab4 orchestrates a small GTPase cascade for recruitment of adaptor proteins to 
early endosomes." Curr Biol 24(11): 1187-1198. 
 
Davenport, A. P., K. A. Hyndman, N. Dhaun, C. Southan, D. E. Kohan, J. S. Pollock, D. 





Devine, C. E., A. V. Somlyo and A. P. Somlyo (1972). "Sarcoplasmic reticulum and 
excitation-contraction coupling in mammalian smooth muscles." J Cell Biol 52(3): 690-
718. 
 
Elkins, T., B. Ganetzky and C. F. Wu (1986). "A Drosophila mutation that eliminates a 
calcium-dependent potassium current." Proc Natl Acad Sci U S A 83(21): 8415-8419. 
Eric Widmaier, K. T. S., Hershel Raff, et al. (2002). "Vander's Human Physiology." 
Vander's Human Physiology. 
 
Evanson, K. W., J. P. Bannister, M. D. Leo and J. H. Jaggar (2014). "LRRC26 is a 
functional BK channel auxiliary gamma subunit in arterial smooth muscle cells." Circ 
Res 115(4): 423-431. 
 
Fernandez-Fernandez, J. M., M. Tomas, E. Vazquez, P. Orio, R. Latorre, M. Senti, J. 
Marrugat and M. A. Valverde (2004). "Gain-of-function mutation in the KCNMB1 
potassium channel subunit is associated with low prevalence of diastolic hypertension." J 
Clin Invest 113(7): 1032-1039. 
 
Harder, D. R., L. Brann and W. Halpern (1983). "Altered membrane electrical properties 
of smooth muscle cells from small cerebral arteries of hypertensive rats." Blood Vessels 
20(3): 154-160. 
 
Harder, D. R., J. Smeda and J. Lombard (1985). "Enhanced myogenic depolarization in 
hypertensive cerebral arterial muscle." Circ Res 57(2): 319-322. 
 
Heitzer, T., U. Wenzel, U. Hink, D. Krollner, M. Skatchkov, R. A. Stahl, R. MacHarzina, 
J. H. Brasen, T. Meinertz and T. Munzel (1999). "Increased NAD(P)H oxidase-mediated 
superoxide production in renovascular hypertension: evidence for an involvement of 
protein kinase C." Kidney Int 55(1): 252-260. 
 
Hilgers, R. H. and R. C. Webb (2005). "Molecular aspects of arterial smooth muscle 
contraction: focus on Rho." Exp Biol Med (Maywood) 230(11): 829-835. 
 
Horinouchi, T., K. Terada, T. Higashi and S. Miwa (2013). "Endothelin receptor 
signaling: new insight into its regulatory mechanisms." J Pharmacol Sci 123(2): 85-101. 
 
Hou, S., S. H. Heinemann and T. Hoshi (2009). "Modulation of BKCa channel gating by 
endogenous signaling molecules." Physiology (Bethesda) 24: 26-35. 
 
Hu, X. Q. and L. Zhang (2012). "Function and regulation of large conductance Ca2+-
activated K+ channel in vascular smooth muscle cells." Drug Discov Today 17(17-18): 
974-987. 
 
Idkowiak-Baldys, J., A. Baldys, J. R. Raymond and Y. A. Hannun (2009). "Sustained 
receptor stimulation leads to sequestration of recycling endosomes in a classical protein 




Inoue, A., M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto and T. Masaki 
(1989). "The human endothelin family: three structurally and pharmacologically distinct 
isopeptides predicted by three separate genes." Proc Natl Acad Sci U S A 86(8): 2863-
2867. 
 
Ito, M. and D. J. Hartshorne (1990). "Phosphorylation of myosin as a regulatory 
mechanism in smooth muscle." Prog Clin Biol Res 327: 57-72. 
 
Ivey, M. E., N. Osman and P. J. Little (2008). "Endothelin-1 signalling in vascular 
smooth muscle: pathways controlling cellular functions associated with atherosclerosis." 
Atherosclerosis 199(2): 237-247. 
 
Jaggar, J. H., V. A. Porter, W. J. Lederer and M. T. Nelson (2000). "Calcium sparks in 
smooth muscle." Am J Physiol Cell Physiol 278(2): C235-256. 
 
Jaggar, J. H., A. S. Stevenson and M. T. Nelson (1998). "Voltage dependence of Ca2+ 
sparks in intact cerebral arteries." Am J Physiol 274(6 Pt 1): C1755-1761. 
 
Jaggar, J. H., G. C. Wellman, T. J. Heppner, V. A. Porter, G. J. Perez, M. Gollasch, T. 
Kleppisch, M. Rubart, A. S. Stevenson, W. J. Lederer, H. J. Knot, A. D. Bonev and M. T. 
Nelson (1998). "Ca2+ channels, ryanodine receptors and Ca2+-activated K+ channels: a 
functional unit for regulating arterial tone." Acta Physiol Scand 164(4): 577-587. 
 
Jiang, Y., A. Lee, J. Chen, M. Cadene, B. T. Chait and R. MacKinnon (2002). "Crystal 
structure and mechanism of a calcium-gated potassium channel." Nature 417(6888): 515-
522. 
 
Jiang, Y., A. Pico, M. Cadene, B. T. Chait and R. MacKinnon (2001). "Structure of the 
RCK domain from the E. coli K+ channel and demonstration of its presence in the human 
BK channel." Neuron 29(3): 593-601. 
 
Jimenez, R., R. Lopez-Sepulveda, M. Kadmiri, M. Romero, R. Vera, M. Sanchez, F. 
Vargas, F. O'Valle, A. Zarzuelo, M. Duenas, C. Santos-Buelga and J. Duarte (2007). 
"Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-
1 and NADPH oxidase." Free Radic Biol Med 43(3): 462-473. 
 
Joseph, B. K., K. M. Thakali, C. L. Moore and S. W. Rhee (2013). "Ion channel 
remodeling in vascular smooth muscle during hypertension: Implications for novel 
therapeutic approaches." Pharmacol Res 70(1): 126-138. 
 
Kamm, K. E. and J. T. Stull (1985). "The function of myosin and myosin light chain 
kinase phosphorylation in smooth muscle." Annu Rev Pharmacol Toxicol 25: 593-620. 
Kidd, M. W., S. Bulley and J. H. Jaggar (2016). "Angiotensin II reduces the surface 





Kilts, J. D., M. A. Gerhardt, M. D. Richardson, G. Sreeram, G. B. Mackensen, H. P. 
Grocott, W. D. White, R. D. Davis, M. F. Newman, J. G. Reves, D. A. Schwinn and M. 
M. Kwatra (2000). "Beta(2)-adrenergic and several other G protein-coupled receptors in 
human atrial membranes activate both G(s) and G(i)." Circ Res 87(8): 705-709. 
 
Knaus, H. G., M. Garcia-Calvo, G. J. Kaczorowski and M. L. Garcia (1994). "Subunit 
composition of the high conductance calcium-activated potassium channel from smooth 
muscle, a representative of the mSlo and slowpoke family of potassium channels." J Biol 
Chem 269(6): 3921-3924. 
 
Kohler, R. (2010). "Single-nucleotide polymorphisms in vascular Ca2+-activated K+-
channel genes and cardiovascular disease." Pflugers Arch 460(2): 343-351. 
 
Kyle, B. D. and A. P. Braun (2014). "The regulation of BK channel activity by pre- and 
post-translational modifications." Front Physiol 5: 316. 
 
Kyle, B. D., S. Hurst, R. D. Swayze, J. Sheng and A. P. Braun (2013). "Specific 
phosphorylation sites underlie the stimulation of a large conductance, Ca2+-activated K+ 
channel by cGMP-dependent protein kinase." FASEB J 27(5): 2027-2038. 
 
Lange, A., D. Gebremedhin, J. Narayanan and D. Harder (1997). "20-
Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium 
current in cerebral vascular smooth muscle is dependent on activation of protein kinase 
C." J Biol Chem 272(43): 27345-27352. 
 
Leo, M. D., J. P. Bannister, D. Narayanan, A. Nair, J. E. Grubbs, K. S. Gabrick, F. A. 
Boop and J. H. Jaggar (2014). "Dynamic regulation of β1 subunit trafficking controls 
vascular contractility." Proc Natl Acad Sci U S A 111(6): 2361-2366. 
 
Leo, M. D., S. Bulley, J. P. Bannister, K. P. Kuruvilla, D. Narayanan and J. H. Jaggar 
(2015). "Angiotensin II stimulates internalization and degradation of arterial myocyte 
plasma membrane BK channels to induce vasoconstriction." Am J Physiol Cell Physiol 
309(6): C392-402. 
 
Leo, M. D., X. Zhai, P. Muralidharan, K. P. Kuruvilla, S. Bulley, F. A. Boop and J. H. 
Jaggar (2017). "Membrane depolarization activates BK channels through ROCK-
mediated β1 subunit surface trafficking to limit vasoconstriction." Sci Signal 10(478). 
Lesh, R. E., G. F. Nixon, S. Fleischer, J. A. Airey, A. P. Somlyo and A. V. Somlyo 
(1998). "Localization of ryanodine receptors in smooth muscle." Circ Res 82(2): 175-
185. 
 
Li, P. F., C. Maasch, H. Haller, R. Dietz and R. von Harsdorf (1999). "Requirement for 
protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle 




Liu, Y., A. G. Hudetz, H. G. Knaus and N. J. Rusch (1998). "Increased expression of 
Ca2+-sensitive K+ channels in the cerebral microcirculation of genetically hypertensive 
rats: evidence for their protection against cerebral vasospasm." Circ Res 82(6): 729-737. 
 
Luscher, T. F., L. L. Aarhus and P. M. Vanhoutte (1990). "Indomethacin improves the 
impaired endothelium-dependent relaxations in small mesenteric arteries of the 
spontaneously hypertensive rat." Am J Hypertens 3(1): 55-58. 
 
Ma, Z., X. J. Lou and F. T. Horrigan (2006). "Role of charged residues in the S1-S4 
voltage sensor of BK channels." J Gen Physiol 127(3): 309-328. 
 
McNair, L. L., D. A. Salamanca and R. A. Khalil (2004). "Endothelin-1 promotes Ca2+ 
antagonist-insensitive coronary smooth muscle contraction via activation of epsilon-
protein kinase C." Hypertension 43(4): 897-904. 
 
Michihara, A., A. Oda and M. Mido (2016). "High Expression Levels of NADPH 
Oxidase 3 in the Cerebrum of Ten-Week-Old Stroke-Prone Spontaneously Hypertensive 
Rats." Biol Pharm Bull 39(2): 252-258. 
 
Montezano, A. C., M. Dulak-Lis, S. Tsiropoulou, A. Harvey, A. M. Briones and R. M. 
Touyz (2015). "Oxidative stress and human hypertension: vascular mechanisms, 
biomarkers, and novel therapies." Can J Cardiol 31(5): 631-641. 
 
Moodie, S. A., B. M. Willumsen, M. J. Weber and A. Wolfman (1993). "Complexes of 
Ras.GTP with Raf-1 and mitogen-activated protein kinase kinase." Science 260(5114): 
1658-1661. 
 
Nabika, T., Z. Cui and J. Masuda (2004). "The stroke-prone spontaneously hypertensive 
rat: how good is it as a model for cerebrovascular diseases?" Cell Mol Neurobiol 24(5): 
639-646. 
 
Nara, M., P. D. Dhulipala, Y. X. Wang and M. I. Kotlikoff (1998). "Reconstitution of β-
adrenergic modulation of large conductance, calcium-activated potassium (Maxi-K) 
channels in Xenopus oocytes. Identification of the camp-dependent protein kinase 
phosphorylation site." J Biol Chem 273(24): 14920-14924. 
 
Narayanan, D., S. Bulley, M. D. Leo, S. K. Burris, K. S. Gabrick, F. A. Boop and J. H. 
Jaggar (2013). "Smooth muscle cell transient receptor potential polycystin-2 (TRPP2) 
channels contribute to the myogenic response in cerebral arteries." J Physiol 591(20): 
5031-5046. 
 
Nelson, M. T., J. B. Patlak, J. F. Worley and N. B. Standen (1990). "Calcium channels, 
potassium channels, and voltage dependence of arterial smooth muscle tone." Am J 




Nieves-Cintron, M., G. C. Amberg, C. B. Nichols, J. D. Molkentin and L. F. Santana 
(2007). "Activation of NFATc3 down-regulates the beta1 subunit of large conductance, 
calcium-activated K+ channels in arterial smooth muscle and contributes to 
hypertension." J Biol Chem 282(5): 3231-3240. 
 
Nozoe, M., Y. Hirooka, Y. Koga, Y. Sagara, T. Kishi, J. F. Engelhardt and K. Sunagawa 
(2007). "Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius 
decreases blood pressure and heart rate in stroke-prone spontaneously hypertensive rats." 
Hypertension 50(1): 62-68. 
 
Ogiku, N., H. Sumikawa, Y. Hashimoto and R. Ishida (1993). "Prophylactic effect of 
imidapril on stroke in stroke-prone spontaneously hypertensive rats." Stroke 24(2): 245-
252. 
 
Okamoto, K. and K. Aoki (1963). "Development of a strain of spontaneously 
hypertensive rats." Jpn Circ J 27: 282-293. 
 
Pabbidi, M. R., O. Mazur, F. Fan, J. M. Farley, D. Gebremedhin, D. R. Harder and R. J. 
Roman (2014). "Enhanced large conductance K+ channel activity contributes to the 
impaired myogenic response in the cerebral vasculature of Fawn Hooded Hypertensive 
rats." Am J Physiol Heart Circ Physiol 306(7): H989-H1000. 
 
Panico, C., Z. Luo, S. Damiano, F. Artigiano, P. Gill and W. J. Welch (2009). "Renal 
proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles 
of superoxide and Na+/H+ exchanger 3." Hypertension 54(6): 1291-1297. 
 
Pavarotti, M., A. Capmany, N. Vitale, M. I. Colombo and M. T. Damiani (2012). "Rab11 
is phosphorylated by classical and novel protein kinase C isoenzymes upon sustained 
phorbol ester activation." Biol Cell 104(2): 102-115. 
 
Pfeffer, S. (2005). "A model for Rab GTPase localization." Biochem Soc Trans 33(Pt 4): 
627-630. 
 
Porter, V. A., A. D. Bonev, H. J. Knot, T. J. Heppner, A. S. Stevenson, T. Kleppisch, W. 
J. Lederer and M. T. Nelson (1998). "Frequency modulation of Ca2+ sparks is involved in 
regulation of arterial diameter by cyclic nucleotides." Am J Physiol 274(5 Pt 1): C1346-
1355. 
 
Proud, C. G. (2004). "Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy." 
Cardiovasc Res 63(3): 403-413. 
 
Quaschning, T., B. Hocher, S. Ruhl, A. Kraemer-Guth, J. Tilgner, C. Wanner and J. Galle 
(2006). "Vasopeptidase inhibition normalizes blood pressure and restores endothelial 




Rainbow, R. D., R. I. Norman, D. E. Everitt, J. L. Brignell, N. W. Davies and N. B. 
Standen (2009). "Endothelin-I and angiotensin II inhibit arterial voltage-gated K+ 
channels through different protein kinase C isoenzymes." Cardiovasc Res 83(3): 493-500. 
 
Robertson, B. E., R. Schubert, J. Hescheler and M. T. Nelson (1993). "cGMP-dependent 
protein kinase activates Ca2+-activated K+ channels in cerebral artery smooth muscle 
cells." Am J Physiol 265(1 Pt 1): C299-303. 
 
Robertson, B. E., R. Schubert, J. Hescheler and M. T. Nelson (1993). "cGMP-dependent 
protein kinase activates Ca2+-activated K+ channels in cerebral artery smooth muscle 
cells." Am J Physiol 265(1 Pt 1): C299-303. 
 
Salamanca, D. A. and R. A. Khalil (2005). "Protein kinase C isoforms as specific targets 
for modulation of vascular smooth muscle function in hypertension." Biochem Pharmacol 
70(11): 1537-1547. 
 
Santana, L. F., E. G. Kranias and W. J. Lederer (1997). "Calcium sparks and excitation-
contraction coupling in phospholamban-deficient mouse ventricular myocytes." J Physiol 
503 ( Pt 1): 21-29. 
 
Schmidt, A. and A. Hall (2002). "Guanine nucleotide exchange factors for Rho GTPases: 
turning on the switch." Genes Dev 16(13): 1587-1609. 
 
Schubert, R. and M. T. Nelson (2001). "Protein kinases: tuners of the BKCa channel in 
smooth muscle." Trends Pharmacol Sci 22(10): 505-512. 
 
Schubert, R., T. Noack and V. N. Serebryakov (1999). "Protein kinase C reduces the KCa 
current of rat tail artery smooth muscle cells." Am J Physiol 276(3 Pt 1): C648-658. 
 
Shi-Wen, X., Y. Chen, C. P. Denton, M. Eastwood, E. A. Renzoni, G. Bou-Gharios, J. D. 
Pearson, M. Dashwood, R. M. du Bois, C. M. Black, A. Leask and D. J. Abraham (2004). 
"Endothelin-1 promotes myofibroblast induction through the ETA receptor via a 
rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced 
contractile phenotype of fibrotic fibroblasts." Mol Biol Cell 15(6): 2707-2719. 
 
Somlyo, A. P. and A. V. Somlyo (2003). "Ca2+ sensitivity of smooth muscle and 
nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase." 
Physiol Rev 83(4): 1325-1358. 
 
Stefani, E., M. Ottolia, F. Noceti, R. Olcese, M. Wallner, R. Latorre and L. Toro (1997). 
"Voltage-controlled gating in a large conductance Ca2+-sensitive K+channel (hslo)." Proc 
Natl Acad Sci U S A 94(10): 5427-5431. 
 
Stenmark, H. (2009). "Rab GTPases as coordinators of vesicle traffic." Nat Rev Mol Cell 




Sutko, J. L. and J. A. Airey (1996). "Ryanodine receptor Ca2+ release channels: does 
diversity in form equal diversity in function?" Physiol Rev 76(4): 1027-1071. 
Taguchi, K., K. Kaneko and T. Kubo (2000). "Protein kinase C modulates Ca2+-activated 
K+ channels in cultured rat mesenteric artery smooth muscle cells." Biol Pharm Bull 
23(12): 1450-1454. 
 
Tang, X. D., L. C. Santarelli, S. H. Heinemann and T. Hoshi (2004). "Metabolic 
regulation of potassium channels." Annu Rev Physiol 66: 131-159. 
 
Uebele, V. N., A. Lagrutta, T. Wade, D. J. Figueroa, Y. Liu, E. McKenna, C. P. Austin, 
P. B. Bennett and R. Swanson (2000). "Cloning and functional expression of two families 
of beta-subunits of the large conductance calcium-activated K+ channel." J Biol Chem 
275(30): 23211-23218. 
 
Wallner, M., P. Meera and L. Toro (1999). "Molecular basis of fast inactivation in 
voltage and Ca2+-activated K+ channels: a transmembrane beta-subunit homolog." Proc 
Natl Acad Sci U S A 96(7): 4137-4142. 
 
Wang, C. L., L. W. Wang, S. A. Xu, R. C. Lu, V. Saavedra-Alanis and J. Bryan (1991). 
"Localization of the calmodulin- and the actin-binding sites of caldesmon." J Biol Chem 
266(14): 9166-9172. 
 
Wang, Y. W., J. P. Ding, X. M. Xia and C. J. Lingle (2002). "Consequences of the 
stoichiometry of Slo1 alpha and auxiliary beta subunits on functional properties of large-
conductance Ca2+-activated K+ channels." J Neurosci 22(5): 1550-1561. 
 
White, R. E., J. P. Kryman, A. M. El-Mowafy, G. Han and G. O. Carrier (2000). "cAMP-
dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate 
BK(Ca) channel activity in coronary artery smooth muscle cells." Circ Res 86(8): 897-
905. 
 
White, R. E., J. P. Kryman, A. M. El-Mowafy, G. Han and G. O. Carrier (2000). "cAMP-
dependent vasodilators cross-activate the cGMP-dependent protein kinase to stimulate 
BKCa channel activity in coronary artery smooth muscle cells." Circ Res 86(8): 897-905. 
 
Woodsome, T. P., A. Polzin, K. Kitazawa, M. Eto and T. Kitazawa (2006). "Agonist- and 
depolarization-induced signals for myosin light chain phosphorylation and force 
generation of cultured vascular smooth muscle cells." J Cell Sci 119(Pt 9): 1769-1780. 
 
Wu, R. S. and S. O. Marx (2010). "The BK potassium channel in the vascular smooth 
muscle and kidney: α- and β-subunits." Kidney Int 78(10): 963-974. 
 
Wynne, B. M., C. W. Chiao and R. C. Webb (2009). "Vascular Smooth Muscle Cell 
Signaling Mechanisms for Contraction to Angiotensin II and Endothelin-1." J Am Soc 




Xia, Z. and Y. Liu (2001). "Reliable and global measurement of fluorescence resonance 
energy transfer using fluorescence microscopes." Biophys J 81(4): 2395-2402. 
 
Yan, J. and R. W. Aldrich (2012). "BK potassium channel modulation by leucine-rich 
repeat-containing proteins." Proc Natl Acad Sci U S A 109(20): 7917-7922. 
 
Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. 
Yazaki, K. Goto and T. Masaki (1988). "A novel potent vasoconstrictor peptide produced 
by vascular endothelial cells." Nature 332(6163): 411-415. 
 
Yang, D., P. Gluais, J. N. Zhang, P. M. Vanhoutte and M. Feletou (2004). "Endothelium-
dependent contractions to acetylcholine, ATP and the calcium ionophore A 23187 in 
aortas from spontaneously hypertensive and normotensive rats." Fundam Clin Pharmacol 
18(3): 321-326. 
 
Yang, H., G. Zhang and J. Cui (2015). "BK channels: multiple sensors, one activation 
gate." Front Physiol 6: 29. 
 
Zerial, M. and H. McBride (2001). "Rab proteins as membrane organizers." Nat Rev Mol 
Cell Biol 2(2): 107-117. 
 
Zhai, X., M. D. Leo and J. H. Jaggar (2017). "Endothelin-1 Stimulates Vasoconstriction 
Through Rab11A Serine 177 Phosphorylation." Circ Res 121(6): 650-661. 
 
Zhou, M. S., H. Kosaka, R. X. Tian, Y. Abe, Q. H. Chen, H. Yoneyama, A. Yamamoto 
and L. Zhang (2001). "L-Arginine improves endothelial function in renal artery of 
hypertensive Dahl rats." J Hypertens 19(3): 421-429. 
 
Zhou, X. B., I. Wulfsen, E. Utku, U. Sausbier, M. Sausbier, T. Wieland, P. Ruth and M. 
Korth (2010). "Dual role of protein kinase C on BK channel regulation." Proc Natl Acad 
Sci U S A 107(17): 8005-8010. 
 
ZhuGe, R., R. A. Tuft, K. E. Fogarty, K. Bellve, F. S. Fay and J. V. Walsh, Jr. (1999). 
"The influence of sarcoplasmic reticulum Ca2+ concentration on Ca2+ sparks and 









 Xue Zhai was born in Tianjin of P.R. China in 1987. During 2006-2013, he 
attended College of Medicine, Nankai University in Tianjin. He obtained his bachelor of 
medicine and master of medicine in June 2013. He joined the Integrated Program in 
Biomedical Sciences (IBS) at the University of Tennessee Health Science Center 
(UTHSC), Memphis in August 2013. He received the Dorothy K. and Daniel L. Gerwin 
Graduate Scholarship which was awarded by the Department of Physiology, UTHSC, in 
July 2015. He presented his research at a poster section of Experimental Biology 
meeting, an international scientific research conference in April 2016. He is expected to 
be awarded his PhD in May 2018. 
 
 
